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Healthcare Associated Infections (HAIs) in the United States, are estimated to 
cost nearly $10 billion1 annually. And, while device-related infections have 
decreased, the 60% attributed to pneumonia, gastrointestinal pathogens and 
surgical site infections (SSIs) remain prevalent2,3. Furthermore, these are often 
complicated by antibacterial resistance that ultimately cause 2 million illnesses 
and 23,000 deaths in the US annually4.  
Antibacterial resistance is an issue increasing in severity as existing antibiotics 
are losing effectiveness, and fewer new antibiotics are being developed. As a 
result, new methods of combating bacterial virulence are required5,6. Modulating 
communications of bacteria can alter phenotype, such as biofilm formation and 
toxin production. Disrupting these communications provides a means of 
 
 
controlling virulence7,8 without directly interacting with the bacteria of interest, a 
strategy contrary to traditional antibiotics.  
Inter- and intra-species bacterial communication is commonly called quorum 
sensing because the communication molecules have been linked to phenotypic 
changes based on bacterial population dynamics. By disrupting the 
communication, a method called ‘quorum quenching’, bacterial phenotype can be 
altered. Virulence of bacteria is both population and species dependent; each 
species will secrete different toxic molecules, and total population will affect 
bacterial phenotype9. Here, the kinase LsrK and lactonase SsoPox were 
combined to simultaneously disrupt two different communication pathways with 
direct ties to virulence leading to SSIs, gastrointestinal infection and pneumonia.  
To deliver these enzymes for site-specific virulence prevention, two naturally 
occurring polymers were used, chitosan and alginate. Chitosan, from crustacean 
shells, and alginate, from seaweed, are frequently studied due to their 
biocompatibility, availability, self-assembly and biodegrading properties10-12 and 
have already been verified in vivo for wound-dressing13 14. In this work, a novel 
functionalized capsule of quorum quenching enzymes and biocompatible 
polymers was constructed and demonstrated to have dual-quenching capability. 
This combination of immobilized enzymes has the potential for preventing biofilm 
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CHAPTER 1 INTRODUCTION 
 
 
Resistance to antibiotics is an issue increasing in severity as existing antibiotics 
are losing effectiveness, and fewer new antibiotics are being developed. As a 
result, new methods of combating bacteria are required to prevent illness and 
infection. Disrupting bacterial communications provides a means of preventing 
the harmful effects of bacteria without directly interacting with the bacteria, a 
strategy contrary to traditional antibiotics.  
Bacterial communication is commonly called quorum sensing because it provides 
a way for a population of bacteria, or quorum, to change behavior of individual 
bacteria. The small chemicals used for communication typically vary between 
types of bacteria, however, one type is recognized by bacteria, plants and 
animals, allowing cross-species communication. By intercepting or modifying 
these small chemicals, a method called ‘quorum quenching’, the individual 
bacterial changes can be prevented, and thereby preventing virulence or 
infection. 
Figure 1: Functionalized capsule for dual quorum quenching  
The multifunctional quorum quenching capsule developed in this work will be the first to 




Here, two proteins, or enzymes, are used that modify two different 
communication molecules. One chemical was mentioned earlier and provides 
inter- and intra-species communication, the other is specific to a handful of 
bacteria which are particularly troublesome. These enzymes, by modifying the 
small chemicals, demonstrate the capability to alter bacterial behavior, which in-
turn could reduce effects of bacterial infection when the enzymes are present.  
To deliver these enzymes to a specific site, two naturally-occurring polymers are 
used, chitosan and alginate. Chitosan, from crustacean shells, and alginate, from 
seaweed, are already used for drug delivery and wound-dressing, so have been 
demonstrated safe to use in humans. Using chitosan and alginate to construct a 
capsule with both enzymes, the capsule was demonstrated to modify two both 
communication chemicals and subsequent behavior of bacteria. This 
combination of enzymes has the potential for preventing infection and reducing 
the harmful impacts of bacterial in a wide variety of applications. 
1.1 Background 
Healthcare Associated Infections (HAIs) in the United States were estimated to 
cost nearly $10 billion annually1 for nearly one million infections3. There are 
commonly four classifications of infection central line-associated bloodstream 
infections (CLABSI), ventilator-associated pneumonia (VAP), surgical site 
infections (SSIs) and catheter-associated urinary tract infection (CAUTI). , 
However, a fifth has been increasingly common in recent years, the 
gastrointestinal pathogen, C. difficile,1-3 and has proven more costly than 
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CAUTIs1. Each of these infections is also associated with antibacterial resistant 
infections that cause 2 million illnesses and 23,000 deaths in the US annually4.  
These infections have toxic consequences inside the body, which result in 
extended hospital stays and readmission. In addition, infections increase 
healthcare costs and require the use of broad-spectrum antibiotics, which, if not 
successful, can lead to death 4,15-18. Device-related infections, when bacteria 
form biofilms in medical equipment such as catheters, diagnostics or ventilators, 
can escalate the spread of infection3,19. Broad spectrum antibiotics and 
prophylactic use has precipitated the emergence of antibacterial resistant strains 
(see Figure 2) now prevalent in hospitals and clinical settings that have reached 
alarming proportions4-6.  
 
 
Figure 2: Emergence of Antibiotic Resistance   
The illustration above explains how antibiotic resistance develops as bacteria mutate and 
then the resistant forms proliferate in the prescence of antibiotics. These mutated bacteria 
can even transfer resistance to other bacteria. (courtesy CDC) 
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Less antibiotic discovery and development efforts by pharmaceutical companies’ 
20-22, concern for maintaining healthy bacteria populations23 and increased 
antibiotic resistance has further encumbered treatment options for combating 
biofilm and bacterial pathogen toxicity. As a result, new, and perhaps game-
changing technologies for combating biofilms – from prevention to removal – are 
increasingly being explored.  
1.2 Bacterial Communication – An Alternative to Antibiotics 
Inter- and intra-cellular communication between bacteria via small molecule-
induced signaling, also known as quorum sensing, has been shown to control 
bacterial phenotypes, including biofilm formation and virulence 7-9,24-28. As a 
result, these small molecules, known as autoinducers, are increasingly a focus of 
research in bacterial metabolism. Specifically, the focus has been on interrupting 
the small molecule signaling pathways between bacteria, a method called 
“quorum quenching”, which has shown to reduce the strength or persistence of 
biofilms 29 and their formation 30-32 33.That is, quorum quenching – achieved by 
intercepting, altering, or ‘confusing’ the QS systems that effect molecular 
communication and biofilm formation/development – has emerged as a potential 
mediator of cell pathogenicity that might avoid entirely the use of traditional 
antibiotics 34. An illustration of how quorum sensing and quenching affects the 
bacterial life-cycle is found in Figure 3.  
Biofilms are specifically identified in association with infection and toxicity 
because cells in this state pose greater challenges for treatment and increase 
risk of chronic infection35. When cells form a biofilm they go through a transition 
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from free (planktonic) cells to operating in a colony of cells that function almost 
as a multicellular organism. To begin forming this colony or film, they use the 
autoinducers to determine the concentration of cells and make phenotypic 
changes. These phenotypes, which include increased motility and surface 
attachment, ultimately contribute to film construction. In biofilm formation the cells 
produce and excrete polysaccharides around the colony, which can be 
composed of multiple species. This protective layer formed by the 
exopolysaccharide matrix and the 3-D structure of the film makes it hard to treat 
or remove, even with antibiotics, as the polysaccharide acts as a protective layer 
which the antibiotics often cannot penetrate36. In addition, cells are released back 






1.3 Classes of Quorum Sensing Molecules 
There are several QS system modalities, distinguished primarily by the class of 
their cognate communication or signal molecules. In this work, the focus is on 
two: autoinducer-1 and autoinducer-2.  
Acylhomoserine lactones (AHLs or AI-1) are primarily associated with inter- and 
intra-species bacterial communication in Proteobacteria which includes Gram-
negative bacteria, or those that have both inner and outer membrane layers38. 
However more recently, AHLs have also been associated with the plague39. AI-1 
signal molecules are composed of a homoserine lactone ring attached to a fatty 
Figure 3: Illustration of quorum sensing and quorum quenching  
This illustrates how autoinducers, here AI-1 and AI-2, contribute to pathogenicity and biofilm 
formation. In addition it illustrates how quorum quenching can reduce growth, pathogenicity and 
biofilm formation by interrupting the autoinducer signaling. 
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or nonfatty acyl group and are detected by LuxI/R. This acyl group can vary 
greatly in size, from a 4-carbon to 18-carbon chain with a single species using 
more than one, and varying from species to species 7,9,38,40. 
A second class of communication molecules, autoinducer-2 (AI-2), is often 
referred to as the ‘universal’ molecule as it is produced by scores of bacteria, 
including both Gram-negative and Gram-positive species, and is also recognized 
by eukaryotic organisms 8,41,42. AI-2 molecules consist of varying forms43-45, and 
include a boronated ring structure in transduction systems that utilize cell surface 
receptors 46-48. AI-2 is produced as part of the activated methyl cycle in bacteria, 
a by-product of the conversion of s-ribosylhomocysteine (SRH) to homocysteine 
(HCY) by LuxS 48.  
 
1.4 ‘Quenching’ Bacterial Communication  
As mentioned, there are several methods of quorum quenching: intercepting, 
altering, or ‘confusing’ the QS systems. Intercepting or altering the molecules is 
straight-forward – elimination or modification to the molecule of interest. To 
confuse the system, molecular analogs interrupt communication by inserting into 
the native molecular ‘network’ a natural or chemically-synthesized, highly similar 
molecule that functions to supplant the natural molecules and affect downstream 
behavior. This method of quorum quenching by ‘confusing’ the system has 
become increasingly prevalent as evidenced by the issue of several analog 
patents 49-53. While analogs have been shown effective in providing an alternative 
to antibiotics in lab environments, many are ‘one time use’ and therefore not self-
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sustaining, and only a handful have provided a delivery mechanism of their 
quenching capabilities. Engineered bacteria have been demonstrated as a way 
of providing self-sustained treatment29 54 55 56,57, and there are recent examples 
of bacteria that provide quorum quenching while contained in capsules and films 
29,58.  
 
It has previously been shown that lactonases are capable of quenching AHL 
quorum sensing by hydrolyzing the AHL. This prevents the molecule from binding 
to the receptor in the cell59. Lactonases hydrolyze AHLs at the C3 ketone as 
illustrated in Figure 4, and can also reduce 
the acyl chain of AHLs to make them 
branched or unsaturated. The action of 
lactonases to mediate quorum sensing has 
been successful in reducing biofilm 
development and in the reduction of pre-formed biofilms. However, ‘neutralizing’ 
this class of molecules enzymatically is challenging as they are quite diverse. As 
a result, any specific lactonase may be effective in neutralizing some AHLs but 
not others 60. This specificity in targeting could be either a benefit or a limitation, 
depending on the application. Kyeong et al. used docking analysis to design 
lactonases that were specifically targeting short acyl chain AHLs 61. In contrast, 
Hiblot et al. has worked with several lactonases from extremophiles, including 
SsoPox, from the hyperthermophilic Sulfolobus solfataricus62, which has been 
Figure 4. Hydrolysis of C3 Ketone  
This provides a simplified illustration of 
the hydrolysis of the C3 ketone on an 
AHL. Here, the R represents the 
remainder of the acyl chain. 
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shown to hydrolyze a variety of acyl chain lengths, making it effective in quorum 
quenching against a wide variety of Gram-negative bacteria 63,64. 
 
AI-2 was chosen for interception for several reasons: it is used in signaling in 
both Gram-positive and Gram-negative bacteria8, it is not produced by eukaryotic 
cells48, the mechanism of AI-2 phosphorylation is understood65, and its 
production is based on positive-feedback8. AI-2 is also associated with biofilm 
formation in Klebsiella, E. coli, Salmonella, Enterobacter and Yersinia 66,67. 
Analogs are a common means of targeting activities of the ‘universal’ quorum 
sensing molecule autoinducer-2 (AI-2). From interfering with production 68, to 
forms of AI-2 precursors 69, to insertion of inert analogs which prevent 
downstream processing 52,70, quorum sensing inhibitors (QSIs) have been 
identified which interfere with nearly every step of the AI-2 life-cycle.  
Use of enzymes to alter or destroy the molecule is less common. Though, 
Varnika Roy of the Bentley Lab showed that the E. coli AI-2 kinase, LsrK, can 
phosphorylate AI-2 in vitro, and that this extracellular phosphorylation of AI-2, 
prevents its uptake, obviating its natural activity71. She went on to show this 
reduced the native quorum sensing response in E. coli, Salmonella typhimurium 
and Vibrio harveyi 71. The mechanism of AI-2 phosphorylation by LsrK with ATP 
was further elaborated by Zhu, et al 65. Building on Varnika’s work by expanding 
the possible mechanisms for use of LsrK in quorum quenching is a critical 




Beads, films and capsules composed of naturally occurring polymers are 
increasingly being studied for use in a wide variety of pharmaceutical and anti-
bacterial applications10-12,29,72,73. Many are using chitosan and alginate due to 
their biocompatibility, availability and biodegrading properties, as well as ease of 
construction due to formation of polyelectrolyte complexes (PECs), a result of the 
opposite charges of chitosan and alginate74-78. In the Bentley Lab these two 
biopolymers were used to construct a simple capsule which contained an 
enzyme-complex produced in the lab10. These capsules formed the starting point 
for development of the robust chitosan-alginate capsules formed here. These two 
molecules not only self-assemble, but are already used as wound-dressing13 14 
and for enzymatic and antibiotic drug delivery 77 79.  
1.6 Research Motivation 
Recent estimates of the number of annual HAIs is lower than in previous years 
700,000 vs 1.7M, however the majority are still attributed to non-device related 
pneumonia, surgical site infections and gastrointestinal infections3. These types 
of infections have not received the same focus as device-related infections3. As a 
result, it is important that focus continue to be placed on preventing these 
infections in the patient. 
The most common pathogens found in infection are: C. difficile, S. aureus, 
Enterobacteriaceae – including Klebsiella, E. coli, and Enterobacter – and P. 
aeruginosa 3, and, each of these has exhibited antibiotic resistance, or been 
associated with antibiotic resistance80. Methicillin-resistant Staphylococcus 
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aureus, MRSA, has received a significant amount of press, and as a result of 
surveillance and improved practices has decreased in the UK and US, however it 
has seen a rise in India and non-hospital related infections80 .  
The family of bacteria Enterobacteriaceae includes Salmonella, E. coli, Yersinia 
(plague), Klebsiella (pneumonia) and Shigella (diarrheal), which are Gram-
negative bacteria and commonly known pathogens. Of these, Klebsiella, E. coli, 
Salmonella, Enterobacter and Yersinia have been found to have both the LuxS, 
AI-2 producing, and Lsr/Lsr-like, AI-2 recognition systems 66,67. Addition of the 
recognition system to Shigella proved to provide a growth advantage81 indicating 
that the presence of the recognition system is indicative of AI-2 affecting bacterial 
growth. Furthermore, AI-2 has been specifically linked to biofilm formation in 
Salmonella and E.coli 82.  
In addition to the family Enterocateriaceae, biofilm formation in S. pneumoniae 
has also been found to be positively regulated by the LuxS system in cultures 
both with and without human cells26. It has also been shown that a quorum 
sensing peptide, or AIP, contributes to biofilm formation under certain in vivo 
conditions83. Similarly, though the exact mechanisms are still under debate it is 
accepted that the AI-2 system, production and receipt, has a role in S. aureus 
virulence and biofilm formation84,85. 
P. aeruginosa is known to use at least three quorum sensing signals including AI-
2, and two AHLs: BHL/C4-HSL and OdDHL/3-oxo-C12HSL/OdDHL which are 
directly tied to virulence. Specifically, OdDHL binding to LasR activates rhlR and 
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production of the second AHL. Inhibiting OdDHL binding and activation of rhlR 
has been demonstrated to reduced pyocyanin production and biofilm formation in 
vitro and in vivo 86,87 In addition, quenching this molecule, which has adverse 
impacts to mammalian cells and inhibits biofilm formation in Gram-negative 
bacteria provides a broader impact than just neutralizing a P. aeruginosa toxin88. 
Providing a dual quenching capability is important specifically in P. aeruginosa 
because concentrations of AI-2 below 10nM have been found to lead to 
increased virulence and biofilm formation89. As a result, reducing both AI-2 and 
the critical AHL concentration provide improved solutions for preventing toxicity in 
in P. aeruginosa.  
While a complete understanding of the role AI-2 plays in C. difficile biofilm 
formation and virulence has not been determined, the absence of the LuxS 
system in this pathogen does prevent biofilm formation 33. AI-2 production during 
growth mirrors that of many Enterobacteriaceae90 and toxins are only produced 
in the stationary phase91. If reduction of AI-2 limits biofilm formation or an Lsr-like 
recognition system is found, the reduction in AI-2 in the environment could also 
reduce C. difficile toxicity, which is currently attributed to a third class of quorum 
sensing molecules91.  
Delivery of enzymes in lieu of bacteria provides distinct advantages: limiting new 
bacteria introduction and a less-variable, more controlled system9. And while 
there is evidence of delivering quenching enzymes in capsules and on 
membranes 92,93 none have targeted AI-2 or used a combination of enzymes to 
modulate the two types of bacterial communication molecules. By taking this 
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combinatorial approach the functionalized capsule will have a broader range of 
impact – for example, it will not only reduce the concentration of OdDHL which is 
harmful to mammalian and other bacterial cells94, but also reduce the 
concentration of AI-2, a universal signaling molecule which leads to biofilm 
production in several species of bacteria – particularly those exhibiting antibiotic 
resistance.  
1.7 Global Objective and Specific Aims 
This work will engineer and purify proteins for attachment to designed biopolymer 
capsules for the purpose of quenching two different types of quorum sensing 
molecules, AI-1 and AI-2. This dual quenching capability will provide further 
control of phenotypes across several species of bacteria and within species, as 
many use multiple molecules in inter- and intra-species communication. 
 
Self-contained capsules constructed of biocompatible biopolymers to modify the 
molecular dynamics of the AI-2 communication pathway are developed. Newly 
modified forms of the naturally occurring AI-2 kinase, LsrK, which has previously 
been shown to ‘quench’ bacterial communication71 are purified and activity is 
verified during covalent binding. In addition, capsules are constructed to deliver 
the primary substrate, adenosine tri-phosphate (ATP), to provide kinase 
quenching in an in vitro environment. These capsules have the potential to 
reduce biofilm formation of several species of bacteria, and specifically the family 




Using the same capsule developed for delivery of LsrK, the second aim focuses 
on quenching of another prevalent communication molecule of Gram-negative 
bacteria, AHL or AI-1, specifically OdDHL. Reduction of this molecule in the 
presence of P. aeruginosa reduced production of pyocyanin86 which has been 
shown to be responsible for 90-95% of P. aeruginosa’s strains ability to resist 
attack from other bacteria95, capable of altering immune response including 
evasion96 and killing mammalian cells86. To modulate the AHL communication 
pathway, an AHL lactonase, SsoPox, is modified with a hexahistidine-tag for 
purification and a separate tag providing the ability to be covalently bound to a 
surface. For the first time, activity of engineered SsoPox is demonstrated when 
covalently bound to a surface. In addition, SsoPox incorporated into a 
biomaterial-based capsule provides new means of delivery of lactonase and, 
possibly, organophosphate hydrolysis activity.  
 
The third aim will focus on tying the first two elements together to construct a 
multifunctional system of biocompatible materials to intercept two classes of 
bacterial communication molecules. Combining two types of quorum quenching 
enzymes is a new and novel concept. As a result, it must first be demonstrated 
that the two enzymes are active in the same environment, and able to 
simultaneously quench both AI-2 and AI-1 quorum sensing molecules. These two 
enzymes will then be bound to the same capsule used previously to demonstrate 
a novel means of delivering dual quorum quenching capabilities on a 
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biocompatible functionalized device. This combination of quenching enzymes 
has the potential to be far more effective as an alternate to antibiotics as it could 
address virulence of several types of bacteria simultaneously. 
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2 OVERVIEW OF QUORUM SENSING INHIBITION 
2.1 Abstract 
Antibiotics combat virulence by their bactericidal or bacteriostatic activities; 
unfortunately, these medicines are losing effectiveness, marked by the seemingly 
incessant emergence of resistant strains. Moreover, such activities are 
diminished when treating cells in biofilms as opposed to those in a planktonic 
state. Concomitantly, cell-cell communication or quorum sensing (QS) systems 
have emerged as targets for antimicrobials as they represent an orthogonal 
approach to the traditional drugs. Instead of directly inhibiting cellular activity, QS 
‘quenching’ molecules or processes silence virulence by interrupting 
communication; the notion being avoiding ‘cidal’ or ‘static’ activities that represent 
drivers of evolutionary escape. Researchers from microbiology, bioengineering, 
food science, agriculture, soil science, human health, and others, have been 
exploring natural and synthetic molecules to ‘quench’ quorum sensing, combat 
biofilm formation, or promote their removal. In this review, which builds on years 
of study, we focus on results of the last few years. Both compounds and their 
methods of application that effect biofilm-born bacteria by targeting QS are 
highlighted.  
2.2 Introduction 
Biofilms affect a wide variety of processes or conditions in many fields. Biofilm 
formation in mechanical and process systems (biofouling) afflicts HVAC units, 
waste-water treatment and many other filtration systems 97. Preventing and 
combating biofilms on food and food packaging is a significant health problem, as 
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precious food supplies are destroyed due to preventable contamination 98. Also, 
the persistent emergence of drug resistant bacteria within hospitals and clinical 
settings has reached alarming proportions 5,6. For example, bacteria are at times 
‘living’ in biofilms on and in medical equipment that is deployed in diagnostics 
(colonoscopy) or other therapies, exacerbating the fundamental problems 19. 
Confounding these issues of biofilm formation and removal is the fact that many 
pharmaceutical companies have dropped discovery and development efforts to 
meet present and future demands 20-22, and there is interest to maintain healthy 
bacteria while simultaneously eliminating harmful bacteria 23. As a result, new 
and perhaps game-changing technologies for removing biofilms, preventing their 
formation, and reducing their effects are increasingly being explored, particularly 
in academic settings.  
2.3 Targeting QS Communication via Molecular Intervention 
One method increasingly used for effecting bacterial growth and biofilm formation 
is through targeted modulation of bacterial communication. Inter- and intra-
cellular communication between bacteria via small molecule-induced signaling, 
also known as quorum sensing, has been shown to control bacterial phenotypes, 
including biofilm formation and virulence 7-9,24-28. Interrupting the small molecule 
signaling pathways between bacteria, a method called “quorum quenching”, has 
been shown to reduce the strength or persistence of biofilms 29 and their 
formation 30-32. That is, quorum quenching – achieved by intercepting, altering, or 
‘confusing’ QS systems by the use of signal analogs that effect molecular 
communication and biofilm formation and development – has emerged as a 
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potential mediator of cell pathogenicity that might avoid entirely the use of 
traditional antibiotics 34.  
There are several QS system modalities, distinguished primarily by the class of 
their cognate communication or signal molecules. The first identified, autoinducer 
1 (AI-1) is comprised of acylhomoserine lactones (AHLs) and is employed 
primarily by Gram-negative bacteria. AI-1 signal molecules can vary greatly in 
size – stemming from a 4-carbon to 18-carbon acyl chain, they vary from species 
to species and a single species may recognize more than one AI-1 molecule 
7,38,40. A second, autoinducer-2 (AI-2), has been referred to as the ‘universal’ 
molecule as it produced by scores of bacteria, including both Gram-negative and 
Gram-positive species. It is also recognized by eukaryotic organisms 8,41,42. AI-2 
molecules consist of either a linear form, which is phosphorylated into an active 
species 43-45, and a boronated ring structure in transduction systems that utilize 
cell surface receptors 46-48. Autoinducer-3 (AI-3), believed to be an aromatic 
compound, is recognized by the same receptors as those that recognize 
epinephrine/norepinephrine and has associated with inter-species signaling 
including that between gut flora and intestinal cells 99. Similarly, autoinducing 
peptides (AIPs) that bind to transmembrane receptors are used by Gram-positive 
bacteria 27,100,101. In addition to these autoinducers, indole-based QS signaling 
has been associated with E. coli, P. aeruginosa, V. cholera and others 102-105 and 
species-specific α-hydroxyketones (AHKs) are used by V. cholera and L. 
pneumophila to regulate virulence and biofilm formation 106-109. Cyclic dimeric 
GMP (cyclic di-GMP or c-di-GMP) is a secondary signaling molecule that 
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regulates both virulence and biofilm formation among other cellular functions 110, 
including increased exopolysaccharide cellulose production 111 and motility 112. 
And recently, peptide signaling in the presence of stress have been increasing 
studied including integration of the QS network and stress network (IQS) in P. 
aeruginosa 113 and peptide signaling in E. coli and S. mutans under stress 
conditions 114-116.  
In the sections that follow, QS and mediators of molecular communication are 
considered as targets for modulating biofilms. We survey the most recent results 
that intersect QS communication with biofilm formation or attenuation. 
2.4 Communication Molecule Analogs  
Signal molecule analogs interrupt communication by inserting into the native 
molecular ‘network’ a natural or chemically-synthesized highly similar molecule 
that functions to supplant the natural molecules and effect downstream behavior. 
This method of quorum quenching by ‘confusing’ the system has become 
increasingly prevalent; several analog patents have been issued 49-53. Brackman 
and Coenye provide a nice comprehensive review with significant chemical detail 
on quorum sensing molecules and their inhibitors 27. We briefly summarize here, 
highlighting features relative to chemical structure. 
 
Several synthetic analogs have been reported targeting activities of the 
‘universal’ quorum sensing molecule autoinducer-2 (AI-2). Kadirvel developed a 
fluoro-analog of the linear form of AI-2, 1,3 dipentandione (DPD); a 4-fluoro-5-
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hydroxypentane-2,3-dione that inhibited bioluminescence and growth of Vibrio 
harveyi 69. Li reported three compounds similar to S-ribosylhomocysteine were 
effective in inhibiting LuxS – the terminal synthase which produces AI-2 as a part 
of the activated methyl cycle. These compounds were shown to inhibit growth of 
swine pathogens A. pleuropneumoniae, H. parasuis and S. suis 68. Roy et al 
developed C-1 alkyl analogs of AI-2 that modify the QS responses of E. coli, S. 
typhimurium, and V. harveyi. These analogs are phosphorylated by the native 
kinase, LsrK, and interfere with the native transcriptional activator, LsrR, and 
therefore modulate AI-2 specific gene transcription (Roy, 2010). Jang and 
coworkers demonstrated that two quorum sensing inhibitors (QSIs) – (5Z)-4-
bromo-5-(bromomethylene)-2(5H)-furanone and D-ribose were effective against 
formation of biofilms by periodontopathogens F. nucleatum, P. gingivalis, T. 
denticola and T. forsythia 117. Brackman et al. showed two molecules mimicking 
the ringed form of autoinducer-2 (AI-2) reduced QS signalling activity among 
reporter strains. That is, thiazolidinediones, which are used to treat diabetes, and 
dioxazaborocanes, which have a boronated ring, interfered with AI-2 quorum 
sensing, reducing signaling by more than 99% (V. harveyi BB170) and 90% (V. 
harveyi MM32). It was also found that the alkylidene chain length in the 
thiazolidinedione derivatives elicited varied effects on quorum quenching 70. 
Gamby also developed analogs affecting E. coli, S. typhimurium, and P. 
aeruginosa 53. The diversity of these analogs and their varying ability to inhibit AI-
2 binding suggest ‘tunable’ quorum quenching. 
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We further note an example of exploiting a combination of AI-2 quorum 
quenching compounds and antibiotics. Roy demonstrated that isobutyl-DPD, a 
C1-alkyl AI-2 analog, inhibited E. coli biofilm maturation with a microfluidic device 
that readily provided biofilm density. They also showed biofilm degradation and 
clearance when used in combination with gentamicin 118.  
 
AI-1 analogues have also been developed which have greater specificity for the 
target bacteria due to species-specific variations in acyl chain length of the native 
forms. This molecular variability is exploited to target specific bacteria, or specific 
signaling pathways in bacteria. For example, Pseudomonas aeruginosa uses at 
least two AHL signaling molecules, 3-oxo-C12-HSL and C4-HSL and exhibits 
several modes of toxicity including production of pyocyanin and pseudolysin 
(LasB) 86,119-121. O’Loughlin analyzed several synthetic molecules that effected 
the P. aeruginosa quorum-sensing receptors, LasR and RhlR, finding that meta-
bromo-thiolactone (mBTL) and chlorolactone (CL) prevented QS-mediated 
production of pyocyanin and biofilm formation 86. Park also demonstrated that an 
alkaloid from the venom of fire ants disrupted quorum sensing and likely targeted 
the rhl system exploiting C4-HSL 120. Stacy was successful in demonstrating that 
AHL analogues prevented the formation of A. baumannii biofilms. In these 
studies they monitored the degree to which various compounds inhibited the 
activity of AbaR – homolog of LuxR -  and measured growth and inhibition of the 
films on plates 122.  
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Interestingly, it has also been shown that a degradation product of the P. 
aeruginosa quorum sensing molecule 3-oxo-C12-homoserine lactone, the 
tetramic acid 3-(1-hydroxydecylidene)-5-(2-hydroxyethyl)pyrrolidine-2,4-dione 
(C(12)-TA), is a potent antibacterial agent 123,124. Lowery determined that the 
mechanism for the antibiotic activity of these molecules was the ability to modify 
the pH gradient and membrane potential of Gram-positive bacteria, proving 
effective against B. anthracis (anthrax), S. aureus (using a methicillin resistant 
strain) and M. tuberculosis (tuberculosis) 123.  
Similar to the work of Roy, Estrela noted that antibiotics and quorum quenching 
provide a more effective means of reducing or eliminating biofilms, specifically 
furanones, increasing P. aeruginosa sensitivity to tobramycin 125. Brackman also 
showed that known quorum sensing inhibitors, baicalin hydrate (BH) or 
cinnamaldehyde (CA), when combined with tobramycin, led to significantly 
greater cell death in P. aeruginosa, B. cenocepacia and B. multivorans biofilms 
than if only tobramycin was used 126.  
 
Polyamines – including norspermidine and spermidine – are a well-studied class 
of linear organic cations that have been shown to exhibit both anti- and pro-
bacterial qualities, perhaps specific to the polyamine and bacteria 127. As such, 
they represent a promising addition to the antimicrobial arsenal. Karatan proved 
that norspermidine, produced by prokaryotes and eukaryotes, is responsible for 
V. cholerae surface accumulation 128. Kolodkin-Gal found that norspermidine acts 
with the D-amino acids of B. subtilis polysaccharide matrix for biofilm 
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disassembly 129. Lee identified an alternative polyamine biosynthetic pathway 
using aspartate β-semialdehyde instead of decarboxylated S-
adenosylmethionine as the aminopropyl group donor in formation of 
norspermidine and spermidine. They later demonstrated that removal of either 
the carboxynorspermidine dehydrogenase (CANSDH) or carboxynorspermidine 
decarboxylase (CANSDC) genes reduced growth rate and biofilm formation and 
noted that this alternate pathway is widespread (Lee, 2009). Nesse found that 
norspermidine and spermidine reduced biofilms of E. coli, but increased S. 
enterica biofilm formation 130. Cockerell, using genomic analysis, determined that 
a variety of bacteria have NspS-like proteins – NspS is responsible for signal 
transduction of spermidine and norspermidine – and determined that polyamine 
signaling is processed by cyclic di-GMP networks 131. We note that spermidine 
has a variety of effects on eukaryotic cells from memory and stress in D. 
melanogaster to reduced translation and growth of mammalian cells 132-134. To 
date, however, much of spermidine research has focused on modifying 
intracellular concentrations of the polyamine: increasing concentrations in S. 
cerevisiae for toxin resistance through mutation 135, or reducing concentration 
with the ornithine decarboxylase inhibitor difluoromethylornithine to treat type I 
diabetes in a mouse model 136. The identification of IQS, which enables LasB 
production even in the absence of C4-HSL 113, may explain why some 
compounds were found to have both antagonist and agonist qualities as well as 
variability across strains 86,126. To combat this process, Zhu found that targeting 
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LasB with mercaptoacetamides was effective in reducing toxicity of P. 
aeruginosa in vivo in C. elegans 121. 
Peptides have been shown to have rolls in inter-, intra-bacterial species signaling 
as well as between bacterial cells and eukaryotic cells 137. S. aureus uses at least 
four classes of auto-inducing peptides (AIPs) with specific transmembrane 
receptors for quorum sensing, recently Tal-Gan et al. determined the structural 
characteristics required to modulate these quorum sensing signals through 
analogs 138. Several other studies exist in which natural and known drug agonists 
were identified to disrupt AIP systems and attenuate toxicity 139,140. Guo et al. 
found that their synthetic peptide was effective at reducing the target S. mutans 
population without adversely affecting beneficial bacterial in an oral biome 
environment 141. In some cases, such as Extracellular Death Factor (EDF) 
peptides released by P. aeruginosa and B. subtilis, species have demonstrated 
the capability to trigger cell-death in other species, in this case E. coli 116. Recent 
research has also found links between bacterial peptide signaling and initiation of 
colon cancer cell proliferation 142, demonstrating a possible correlation between a 
person’s microbiome and cancer susceptibility.  
 
Indole signaling has also been associated with reduced biofilm formation by 
inducing SdiA-mediated transcription 104. Notably, indole marginalized EHEC and 
P. aeruginosa  infections 143,144 indirect correlations between E. coli biofilm 
formation and indole concentration 145. Bunders demonstrated that 
desformylflustrabromine (dFBr) and derivatives were similarly effective in 
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inhibiting biofilm formation in E. coli and S. aureus through interactions with the 
transcriptional regulator SdiA 105.  
To combat virulence of L. pneumophila, Harrison focused on inhibiting its 
replication in the host cells, specifically intracellular replication in ‘Legionella-
containing vacuoles’ (LCVs) as these bacteria are typically ‘protected’ from 
antibiotics. Harrison demonstrated successful reduction of intracellular replication 
using a synthetic compound and showed that A. castellanii provides a viable way 
to screen for effective inhibitors 146.  
2.5 Naturally-Occurring Quorum Sensing Modulation 
On several occasions naturally occurring molecules have proven effective in 
altering quorum sensing and preventing or dislodging biofilms. Naturally 
occurring furocoumarins – bergmottin and dihydroxybergamottin (DHB) – found 
in grapefruit juice have been shown to quench both AI-1 and AI-2 QS 
transduction pathways in E. coli, S. typhimurium and P. aeruginosa, as measured 
using the V. harveyi BB170 assay. In addition, furocoumarins, or 
furanocoumarins, were shown to impact biofilm growth of both E. coli and S. 
typhimurium 147. Owing to their structural similarity to both AHL and AI-2, 
Bergamottin and DHB are possibly functioning as communication molecule 
analogues. Another naturally-occurring molecule, curcumin, from the spice, 
turmeric (Curcuma longa) inhibited biofilm formation and disturbed existing 
biofilms of E. coli, P. aeruginosa PAO1, P. mirabilis and S. marcescens. 
Curcumin was found to significantly reduce exopolysaccharide production in 
studied organisms and alginate production in PAO1, both of which enable biofilm 
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formation. Curcumin was also demonstrated to effect quorum sensing-associated 
behaviors such as swimming and swarming, and was found to enhance efficacy 
of conventional antibiotics when co-administered, though the specific 
mechanisms were not elucidated 148. Additionally, vanillin, the main component of 
vanilla extract, was shown to have quorum quenching properties against the 
Gram-negative C. violaceum 149 and prevent biofilm formation of A. hydrophila, a 
known biofouling Gram-negative bacterium 97. Choo noted there was no 
structural similarity between vanillin and autoinducers, however. It is interesting 
that in a recent follow-on vanillin reduced growth of E. coli in a food medium 150. 
Additionally, Perez-Montano found that O. sativa (rice) and P. vulgaris (beans) 
produced molecules that despite not having the ring of AHLs were able to modify 
quorum sensing of S. fredii and P ananatis which affect plants 151. 
Inorganic modulators of biofilms have also attenuated QS activity. In addition to 
organic compounds, small concentrations (<1mM) of nickel and cadmium have 
been shown to inhibit B. multivorans biofilm formation without affecting growth. 
Both nickel and cadmium were shown to down-regulate genes associated with 
quorum sensing including bmuIR, the activator gene for C8-HSL production in B. 
multivorans 152. Garcia-Lara et al. used ZnO nanoparticles to demonstrated 
quorum quenching and reduced virulence on clinical strains of P. aeruginosa 153. 
2.6 Enzymatic Effectors of QS Signaling and Biofilm Formation 
Lactonases hydrolyze AHLs at the C3 ketone; they also can reduce the acyl 
chain of AHLs to make them branched or unsaturated. The action of lactonases 
to mediate quorum sensing has been proven successful in reducing biofilm 
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development and in the reduction of pre-formed biofilms. However, ‘neutralizing’ 
this class of molecules enzymatically is challenging as they are quite diverse. As 
a result, any specific lactonase may be effective in neutralizing some AHLs but 
not others 60. This specificity in targeting could be both beneficial or a limitation, 
depending on the application. For example, Hiblot has worked with several 
lactonases from extremophiles that have been shown to hydrolyze a variety of 
acyl chain lengths, making them effective quorum quenching molecules against a 
wide variety of Gram-negatives 63,64. In contrast, Kyeong used docking analysis 
to design lactonases that were specifically targeting short acyl chain AHLs 61. 
Meanwhile, Vinoj tested for specificity, identifying an AHL lactonase produced by 
native gut bacteria of white shrimp (Fenneropenaeus indicus) that reduced 
growth of Vibrio parahaemolyticus as well as its biofilm development 154. Similarly 
Chow engineered a lactonase from Geobacillus kaustophilus, a robust bacterium 
capable of surviving pH 2-10 and 5-78 ºC 155, and demonstrated reduction of A. 
baumannii biofilm mass 156.  
There are other AHL hydrolases, including paraoxonases and acylases. 
Paraoxonase (PON), specifically human paraoxonases, hPON1, hPON2, hPON3 
have been shown to be effective lactonases of the P. aureginosa AHL 3OC12-
HSL, capable of quenching the AI-1 signal and reducing biofilm growth 157,158. 
Acylases, which include both amidases and aminoacylases, hydrolyze amide 
bonds within AHLs; they also have biofilm inhibiting activities 159. Independently, 
acylases have also been shown to inhibit accumulation of quorum sensing 
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molecules, and in turn, regulate virulence 160. Further enzyme engineering of this 
same acylase quenched QS activity of several Burkholderia species 161.  
Enzymes have also been exploited that modulate QS activity based on altering 
the QS signal transduction process, as opposed to degrading the signal 
molecules themselves. Roy showed that the E. coli AI-2 kinase, LsrK, can 
phosphorylate AI-2 in vitro, and demonstrated that AI-2 that was extracellularly 
phosphorylated, prevents its uptake obviating its natural activity. The LsrK activity 
reduced the native quorum sensing response in E. coli, Salmonella typhimurium 
and Vibrio harveyi71. The mechanism of LsrK phosphorylation of AI-2 was shown 
in more detail later 65. Exploitation of kinases, when used in this manner, may 
prove an effective way of modifying other sensing circuits, such as LAI-1 in L. 
pneumophila, where Lqs1 regulates pathogen-host interactions and competence 
109,162.  
2.7 Non-QS mediators of biofilm formation  
Other methods associated with QS-linked phenotypes, but not specifically 
attributed to altered QS activity, also reduce biofilm formation and strength. We 
briefly mention these as they represent interesting pathways for further study. For 
example, quorum sensing is shown to rely on the ability of bacterial cells to swim 
either towards or away from various signal molecules, including QS autoinducers 
as demonstrated by Bansal and Hegde with AI-2 163,164. Should the bacteria be 
non-motile, the effects of these molecules is reduced as cells are less able to co-
locate with either themselves or others to form a biofilm. It has been shown, for 
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example, that expression of surface proteins such as curli, flagella, and pili 
influence biofilm production through chemotaxis-independent means 165-168. 
For example, Pilicides are compounds that prevent pili formation, which in turn 
provide motility. Chorell and coworkers and, independently, Greene and 
coworkers, synthesized pilicides of varying strengths in an effort to reduce the 
ability for E. coli to form a quorum and ultimately a biofilm 169,170. Chabane 
demonstrated that virstatin, known to reduce virulence in V. cholorae, effected 
biogenesis of A. baumannii pili and subsequently reduced biofilm formation and 
strength 171.  
2.8 Delivery Systems for QQ and QS-associated Biofilm Reduction 
There is a great deal of evidence demonstrating the ability of non-traditional 
antibiotics, such as QQ molecules, signaling antagonists, effector enzymes, and 
their application for reducing bacterial pathogenicity and/or reduce biofilms. 
However, effective delivery and targeting of these treatments remains a 
significant technical hurdle and it is becoming increasingly important that 
recognition of the coupling between transport and function can guide future 
advances. For example, beyond the QS inhibition molecules noted above and 
the many we have omitted here but that have been recently reviewed, they have 
limited activity until they are delivered to the cells or within the cells. Further, we 
note that studies, including our own118, show promise to reduce biofilms, but are 
as yet incapable of completely eliminating bacteria from within biofilms. 
Accordingly, we also highlight technological approaches that have emerged to 
elucidate the interactions between QS-inhibiting or biofilm-inhibiting molecules 
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and the bacteria they target. Perhaps these combinatorial methods, also 
proposed by Allen et al 172, will prove more efficacious, in both fundamental study 
and in developing treatment paradigms, as new and more potent molecules are 
discovered.  
That is, in delivering quorum quenching capabilities it may be important that the 
supplied compound remains sequestered from non-target environments, or is 
otherwise released at such a rate that it does not cause harm greater than the 
film it is intended to effect. While not typically described in reviews of quorum 
sensing, the delivery of molecular modulators can be as important as the 
molecule’s function as it ensures effective use or otherwise, complete inability to 
function as a modifying agent. In addition to many materials-based surface 
modification approaches 173-175 there are a few delivery mechanisms have been 
reported recently that work to enhance QS-based molecular effectors. For 
example, by adsorbing acylase onto mesoporus silica spheres, Lee et al. 
demonstrated the attenuation of P. aeruginosa PAO1 biofilm formation on 
filtration membranes used in water treatment systems; importantly, without 
releasing the enzyme into the water 176. Xiong et al provided a review of using 
polymer particles to deliver antibiotics that includes additional examples of this 
method 177. The site-specific assembly of QS-active enzymes was also 
demonstrated by Pei who encoded lactonase synthesis in bacteriophages to 
deliver to biofilm-localized P. aeruginosa and E. coli. In this ‘one-two’ punch 
system, the lactonase quenched AI-1 signaling at the same time as promoting 
lysis of the resident bacteria178. 
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There are also examples of delivering quorum quenching capabilities on 
substances/molecules that have other beneficial qualities. Quorum quenching 
capabilities have also been delivered on reconstituted High Density Lipoproteins 
(reHDL) for distribution in the blood stream. Deakin engineered a chimeric 
protein of PON2 (an intracellular paraoxonase) with PON1 (an extracellular 
paraoxonase) for attachment to reHDL 179. Attaching this chimera provided 
quorum quenching activity on the surface of reHDL, a reconstituted version of 
‘good cholesterol’ in human arteries 180. In addition, Stroescu used vanillin as the 
cross-linking agent for chitosan, which has previously been shown to have anti-
microbial properties 73,181,182, to combine the properties of both compounds 182.  
In recent years, microfluidics have been increasingly used to provide insight into 
microbial growth and behavior 183,184 and test new methods of reducing or 
preventing biofilms 185,186. Previously, microfluidics were used to test a 
combination of quorum quenching techniques and antibiotics 118 and test biofilm 
dispersion 54. And as suggested by Hol and Dekker, nanoparticles have also 
been used to deliver an autoinducer that reduces toxicity in V. cholerae 
capabilities 187 and quorum sensing inhibitors to effect P. aeruginosa 188. 
We also note that for many applications, such ‘single-shot’ treatments for 
prevention or clean-up is insufficient. The techniques described above have also 
served to underpin self-sustaining capabilities that have longer-lasting effects. 
For example, engineered cells can be introduced into various settings that, in 
turn, can provide for sustained treatment., Hong demonstrated a system in which 
an engineered bacterial species was inserted into a biofilm first supplanting the 
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initial cell population and subsequently dispersing the film when prompted by 
chemical induced switch 54. Also, Zargar demonstrated a bacteria that ‘controlled’ 
the common quorum sensing molecule AI-2, providing a constant withdrawal of 
AI-2 from the extracellular milieu that inhibited biofilm formation 55. Gupta and 
Hwang also engineered cells that sensed and destroyed specific species and 
dissipated extant biofilms, respectively 56,57. Additionally, there are recent 
examples of bacteria that provide similar functionality while contained in capsules 
and films so that new bacteria are precluded from entry Oh 58 and Kim 29. 
Finally, several recent studies and reviews have focused on the evolution of 
resistance 189-191 which will also provide insight into how best to combat the 
growing antibiotic resistance problem.  
2.9 Conclusions  
As traditional antibiotics lose efficacy, new ways of fighting bacteria virulence are 
continually being developed, however fewer involve discovery of new antibiotics. 
Using natural and synthetic compounds as well as innovative delivery 
mechanisms new methodologies are emerging that serve to reduce cell growth 
and pathogenicity without killing bacteria. While it is thought this slows the 
evolution of resistant bacteria, there are equally interesting results on the 
evolutionary and modulation of growth and molecular production/release 
capabilities that quorum sensing/quenching molecules may provide. 
Methodologies that target the human microbiome (e.g., the GI tract) are likely to 
be well-received as the impact of overuse of antibiotics is becoming more 
tractable. Additionally, the use of quorum quenching strategies, antibiotic 
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counter-inhibitors, development of new antibiotics and more judicious use of 
existing drugs each offer capabilities to reduce infection and biofouling and have 




3 CHAPTER 3: FUNCTIONALIZED CAPSULE FOR AI-2 
QUORUM QUENCHING  
3.1 Introduction 
Bacterial formation of biofilms becomes toxic to humans and degrades system 
functionality192. These bacterial constructs have been shown to delay wound-
healing193, are problematic in the oral cavity, especially on permanent fixtures194 
or in older patients195 and can form on medical devices196. Detection and removal 
of these destructive films can be difficult and the widespread use of antibiotics to 
prevent toxicity has precipitated the development of antibacterial resistant strains 
which require alternate methods of combating biofilm formation5,6. 
Intercellular communication between bacteria via small molecule-induced 
signaling, also known as quorum sensing, has been shown to control bacterial 
phenotypes, including virulence7,8,24. As a result, these small molecules, known 
as autoinducers, are increasingly a focus of research as a means of controlling 
virulence197. Specifically, the focus has been on interrupting these small molecule 
signaling pathways between bacteria, a method called “quorum quenching”, 
which has been demonstrated to reduce the strength and formation 
biofilms29,89,198.  
In this work, the focus is on intercepting signal reception of a specific 
autoinducer, autoinducer-2 (AI-2), using a natural enzyme delivered with its 
primary reactant in the form of a self-contained capsule. This enzyme, the kinase 
LsrK, derived from E. coli, phosphorylates AI-2 to phospho-AI-2, AI-2P, which 
prevents its cellular uptake as shown previously71. AI-2 was chosen for 
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interception for several reasons: it is used in signaling in both Gram-positive and 
Gram-negative bacteria8, it is not produced in eukaryotic cells48, the mechanism 
of AI-2 phosphorylation is understood65, and its production is based on positive-
feedback8. AI-2 is constitutively expressed in E. coli, and production is increased 
in the presence of AI-2, which leads to the positive feedback effect, and as a 
result, amplification of the AI-2 signal modulation. 
This first enzymatic ‘quorum quenching’ capsule is composed of oppositely 
charged chitosan and alginate contains adenosine 5’-triphosphate (ATP). ATP is 
a common energy carrier in biological systems, and the primary substrate for 
LsrK, in the phosphorylation of ATP. By modifying the powerful AI-2 quenching 
enzyme, LsrK such that it can be bound to both chitosan films and capsules there 
is now a means for local AI-2 quorum quenching capability.  
3.2 Materials & Methods 
 
 LsrK-Tyr and LsrK-Gln 
The plasmid pETLsrK-Tyr was used to express the AI-2 kinase, LsrK, fused with 
a spacer and tyrosine tag, herein referred to as LsrK-Tyr. To construct the 
plasmid, E. coli lsrK (ydeV) was amplified with primers as indicated in Table 1 
from E. coli W3110 genomic DNA using Vent DNA polymerase (New England 
Biolabs; NEB). After purifying the PCR product via the QIAquick gel extraction kit 
(Qiagen), the blunt-ended fragment was inserted into pET200/D-TOPO 
(Invitrogen), which has a hexa-histidine tag at the N-terminus for purification after 
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the protein expression. The sequence of pETLsrK-Tyr was confirmed by 
sequencing facility (DNA Core Facility of the Institute for Bioscience and 
Biotechnology Research, University of Maryland). After transforming the plasmid 
into the BL21 (DE3) host strain, the LsrK-Tyr enzyme (MW: 62.9 kDa) was 
expressed and purified. 
The plasmid pETLsrK-Gln was used to express the AI-2 kinase, LsrK-Gln, fused 
with spacer and glutamine tag, herein referred to as LsrK-Gln. To construct the 
plasmid, the gene LsrK-Tyr was cut from the pET200 backbone with NheI and 
SacI and amplified with Taq polymerase (New England Biolabs; NEB) using 
LsrK-Gln_Fwd and LsrK-Gln_Rev primers obtained from IDT (Coralville, IA, 
USA). After purifying the PCR product via the QIAquick gel extraction kit 
(Qiagen), the gene was digested, and ligated with the previously digested 
pET200 backbone. The sequence of pETLsrK-Gln was confirmed by Genewiz 
(Frederick, MD). After transforming the plasmid into the BL21(DE3) PLysS host 
strain, the LsrK-Gln enzyme (MW: 62.310 kDa) was expressed and purified. 
 
Table 1. Primers for LsrK-X plasmid construction 
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 Reporting Cells 
A modified strain of the AI-2 sensing E. coli, CT104, used by Tsao et al, 2010 
and Gupta et al, 2013 was used to measure and prove quenching. This CT104 
(pCT6-ampr+pET-dsRed-kanr) synthesizes the red fluorescent protein dsRed in 
lieu of AI-2 due to a LuxS mutation 10,199. The BB170 V. harveyi strain was also 
used here to determine AI-2 concentration200.  
 
After growth at 37 °C at 250 rpm, expression of LsrK-Tyr and LsrK-Gln was 
induced by isopropylthio-β-galactoside (IPTG, 1mM final concentration) when cell 
concentrations reached OD600 of 0.4. The cells were swirled in an ice-water slush 
during induction and for several minutes after, which is believed to ultimately de-
repress the heat-shock proteins which aids solubility of foreign proteins201,202. 
The induced culture was incubated at 30 °C, 250 rpm for approximately 16 hours, 
and the cells were collected by centrifugation, discarding the supernatant. The 
cell pellet was re-suspended in phosphate buffered saline (PBS, pH 7.4 0.01M) 
with 10mM imidazole and sonicated using a Fisher Scientific 550 Sonic 
Membrator at power 3 for 15 minutes 0.5 seconds on/off to disrupt the membrane 
and release the protein. After sonication, the solution was centrifuged and the 
supernatant was retained for immediate purification.  
Protein purification was achieved using a Ni2+-loaded GE Healthcare Life 
Sciences HiTrapTM Chelating HP Column, using the hexahistidine-tag on the 
LsrK-Tyr/Gln protein. After loading, the column was ‘rinsed’ with concentrations 
of 10mM and 50mM imidazole, and the enzyme was eluted with 300mM 
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imidazole in IMAC Buffer (50 mM NaPO4, 1.25M NaCl, pH 7.4). The eluted 
enzyme underwent a series dialysis in PBS at 4°C to ensure a less than 100 nM 
concentration of imidazole. The dialyzed enzyme concentration was measured 
using a nanodrop and appropriate MW/Extinction coefficients (LsrK-Tyr: 102.5k, 
LsrK-Gln: 95k) and stored in 40% sterile glycerol in 50-100 µL aliquots at -20°C. 
 
AI-2 produced in vitro was used unless otherwise stated, to best isolate the LsrK-
Tyr activity. The AI-2 was produced using a variation of the nanofactories as 
described in Fernandes et al 203. In this study HLPT was used in lieu of HGLPT 
as the IgG-binding domain was not required.  
 
As was previously stated, LsrK-Tyr, was constructed with a pentatyrosine tag on 
the C-terminus for the binding of the protein to a surface. Specifically this was 
chosen based on success in maintaining activity in other proteins after 
attachment to chitosan 204. Methods similar to Wu et al.204 were used in forming 
chitosan films on 96-well plates, except the films remained in the wells. Chitosan 
(Medium MW, Sigma, St. Louis, MO) was dried either overnight in a 30 °C 
incubator or by vacuum incubation at 30 °C, then neutralized with 1M NaOH. The 
films were rinsed with HEPES, pH 7 (Sigma, St. Louis, MO). LsrK-Tyr was added 
in varying concentrations with 350u of tyrosinase (Sigma, St. Louis, MO) to a 
final volume of 125 µL. After allowing the tyrosinase and LsrK-Tyr to incubate for 
1 hour at 37 °C with shaking, the well was rinsed with 1M NaCl or 50mM HEPES, 
pH 7.0, three times.  
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Verification of LsrK-Tyr binding to chitosan films and capsules was completed 
using LsrK-Tyr labeled with DyLightTM Sulfhydryl-Reactive Dye.  
 
Alginate solution 2.5% (w/v) was made by dissolving medium viscosity alginate 
from brown algae (Sigma, St. Louis, MO) in deionized water. The solution was 
dissolved by heating, without boiling, and magnetic stirring, then filtered with a 
0.22µm Millex®-GP syringe filter (Merck KGaA, Darmstadt, Germany) to remove 
undissolved substances and impurities. Medium molecular weight chitosan 
(MMC) from crab shells, 85% deacylated, (Sigma, St. Louis, MO) was dissolved 
in deionized water (0.8L) containing 2% glacial acetic acid with stirring. The 
chitosan solution was then twice-filtered to remove undissolved substances and 
impurities. This yielded a 2% (w/v), pH 5 solution of chitosan as determined by 
pH test strips 0.0-14.0 (Sigma, St. Louis, MO). A 1% (w/v) calcium chloride 
solution was prepared by dissolving calcium chloride dihydrate, CaCl2, (JT Baker, 
Phillipsburg, NJ) in distilled water, and again the solution was filtered using the 
same Millex® filter to remove impurities. ATP, 100mM, was obtained (Thermo 
Scientific Inc., Rockford, IL) and diluted to 10mM concentration with autoclaved 
MilliQ water (Millipore, Darmstadt, Germany).  
 Capsules 
Initially a robust, tri-lamellar capsule was used to test LsrK-Tyr binding to a 
capsule as a proof of concept. The base of the capsule was an alginate bead 
formed by adding 1% alginate drop-wise via syringe into 1.5M CaCl2. After 
approximately 5 minutes, the beads were removed from the CaCl2 and rinsed in 
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350 µL of 0.15M NaCl. The bead was then transferred to a 0.5% chitosan 
solution, rinsed in 0.15M NaCl, transferred to a 0.5% alginate solution, again 
rinsed in 0.15NaCl, transferred to 0.5% chitosan solution to add the final layer, 
and finally rinsed with 0.15M NaCl. 
Construction of the functionalized uni-lamellar capsules is based on the charged 
polymers chitosan and alginate for self-assembly as has been used in previous 
works10,205 and has been referred to as a one-stage procedure206. ATP (10mM) 
was mixed with alginate (2.5%) for final concentration of 222µM ATP, vortexed, 
and added drop-wise by syringe needle (27G) to a magnetically-stirring solution 
of 1.1% (w/v) chitosan and 0.27% (w/v) CaCl2. The alginate-chitosan capsules 
were left in the solution for 10 minutes before being removed and rinsed in 0.02% 
(w/v) CaCl2. These capsules were then transferred for individual attachment of 
the enzyme. Capsule construction and rinsing was done at room temperature. 
This process is illustrated in Figure 5.  
Figure 5. Capsule construction 
As illustrated in this figure, capsules 
were constructed by dropping a 
mixture of 2.5% w/v filtered alginate 
and 222µM ATP via 27G needle into 
stirring Chitosan-CaCl2 to form 
capsules (A1) which were then 
incubated 10 min (A2). The capsules 
were removed from the incubation 
media and rinsed in 0.02% w/v CaCl2 




 Calculating Amount of bound LsrK-Tyr 
Binding of enzymes to chitosan films and capsules was verified by labeling LsrK-
Tyr with DyLightTM sulfhydryl-reactive dye. The amount of chitosan in the bottom 
of the 96-well plate and surface area of the well was used to calculate amount of 
LsrK-Tyr per surface area of chitosan. The radius of the capsule (1.375 mm) and 
shell thickness of capsules (0.2 mm) were measured immediately after rinsing 
using an MVX10 MacroView fluorescence stereomicroscope (Olympus, Center 
Valley, PA) as shown in Figure 16-B4. This information was used to calculate the 
average surface area of the capsule (.24 cm2) and subsequent amount of bound 
LsrK-Tyr based on the surface area of a well of a 96-well plate (0.32 cm2). The 
Zeiss LSM-310 laser-scanning microscope using the RFP filters was used to 
construct z-stack confocal images seen in Figure 16. 
The chitosan film in the bottom of a 96-well plate was used initially to verify 
binding and estimate binding density. Labeled LsrK-Tyr was incubated with the 
dried chitosan in a 96-well plate (surface area of 0.32 cm2) and a plate reader 
was used to take fluorescent readings during incubation and after rinsing. Using 
these post-rinse fluorescent readings and a standard curve the amount bound 
was calculated as shown in Figure 6.  
Figure 6. LsrK Binding 
Measurements in the chart were 
completed in 96-well plate, illustrated 
to the right of the graph and are the 
average of 3 samples of each 
quantity, taken at the completion of 
incubation (orange) and after 
washing. Error bars represent 
standard deviation. The grey line is a 
standard curve of labeled enzyme, 
and the corresponding linear best-fit 




In addition, the maximum amount of enzyme per surface area was calculated 
using the molecular weight of LsrK-Tyr (62.9kDa) for each well. It is assumed 
LsrK-Tyr is a soluble, globular protein, so the partial specific volume is 0.74 
cm3/g207. Multiplying this by the molecular weight and dividing by molecules per 
mole yields a cubic centimeter estimate of volume per molecule and subsequent 
radius of 2.64x10-7 cm. Assuming a spherical molecule, the surface area this 
sphere would cover can be determined, 2.19x10-13 cm2, and this becomes a 
circle packing problem onto the bottom of a 96-well plate with an area of 0.32 
cm2. While formulas for efficient packing of up to 20 circles have been found208, 
packing additional circles becomes a complex coding optimization problem. As a 
result, for purposes of this work, the square packing hexagon model, also shown 
as 7 circles within a circle as seen in Figure 7, is used to estimate ratio of surface 
area covered. Here the inner circles are the enzyme radius, 2.64x10-7 cm, and 
the radius of the outer circle is 3*(2.64x10-7 cm). As the area of a circle is πr2, 
this means approximately 7/9 or 78% of the surface area is covered. This is the 
same percentage that was found using an online calculator1 and extrapolating, 
where 1.15x1012 molecules, or 1.9 picomoles of LsrK, covering an area of 0.25 
cm2 were found to fit on the bottom surface of a 96-well plate. This translates to 
an area covered by enzyme of .25 cm2, or LsrK-Tyr coverage of 78% of the total 
area, or 5.94 picomoles enzyme per cm2 chitosan. This calculation of coverage 
only considers the estimated size of the enzyme, and does not consider 




additional distance that may occur between enzymes due to repulsion of the 
similarly charged molecules.  
Assuming a single layer of enzyme, this layer is 5.28x10-7 cm thick, while the 
chitosan layer in the well is approximately 0.05 mm thick, meaning the enzyme 
layer is less than 0.1% the size of the chitosan layer. 
 Verifying Activity of LsrK-Tyr/Gln 
To verify that the modified enzyme was active both in solution and attached 
several means were chosen. An ATP assay, Kinase-Glo® Plus (Kinase-Glo 
Luminescent Kinase Assay Platform, Promega, Madison, WI) was used in 
addition to the commonly-used BB170 assay200 55 and a previously developed 
reporter cell, CT104199. AI-2 produced by nanofactories in vitro 203 was used to 
provide a controlled and measurable means of verifying AI-2 quorum sensing 
inhibition. The use of reporter cells to indicate inhibition of quorum sensing is an 
increasingly common means of verifying quorum sensing inhibition 209,210 and use 
of known quantities of AI-2, whether synthetic or in vitro have also been used as 
a measure of quorum sensing 199. The final step in verification of the system was 
using conditioned media from the AI-2 producing E. coli, BL21, incubated with 
the CT104 reporter cells to further demonstrate the quorum quenching 
capabilities using naturally-produced AI-2.  
Figure 7. Circle Packing 




3.3 Results  
 
Both forms of LsrK were purified as described and summarized in Figure 8A. 
Here is presented a comparison of other examples of LsrK purification (A) as well 
as examples of SDS-PAGE gels (B, E) and Western blots (D, F) to verify the 
purity of the enzyme. In addition, an SDS-PAGE of the cell lysate of an empty 
plasmid in the same cell line under the same growth conditions is included in C to 
Figure 8. LsrK modification, expression and purification 
Native E. coli LsrK was modified with two tags and purified used Ni2+ column and dialysis. No 
protein yields have previously been reported as shown in A. Modified LsrK is found on the 
SDS-PAGE gel (B, E) and Western blot (D, F) just above the 55kDa ladder band. The second 
line at approximately 120kDa (twice the size of LsrK) (B, E) was found reduced with ‘old’ 
samples (those stored at 4 °C in PBS without glycerol). In B, the lanes represent the enzyme 
flow-through of column diluted by half, then increasing concentrations of imidazole until elution 
as seen with 150 and 200mM concentrations. In C the gel demonstrates that no enzyme is 
present in the empty plasmid. In D, the lane of the Western to the left of the ladder is the His-
tagged LsrK-Gln. In E, the lane to the left of the ladder is LsrK-Gln and the right is LsrK-Tyr. In 
F, the first lane is the His-tagged LsrK-Tyr and the second lane is an older LsrK-Tyr sample 
(stored at 4 °C in PBS without glycerol). The gel (E) and Western blots (D, F) are 
representative of what was found during purification of at least 5 different instances of growth, 
expression and purification.  
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demonstrate that there is not a band present representing LsrK-Tyr/Gln. It is 
noted that in the SDS-PAGE and Western that a second band, approximately 
twice the weight of LsrK-Tyr/Gln is present on fresh samples but was not as 
visible on samples stored at 4 °C in PBS without glycerol.  
With the next step to verify LsrK-Tyr and LsrK-Gln the linear range of the 
luminescent reporter, BB170 was determined by using a standard of AI-2 
produced in vitro in LB as shown in Figure 9. Here, the values are normalized to 
a negative control of LB and are the result of the average of three samples with 
error bars shown, though only visible for the 40µM sample.  
 
Figure 9. Linear range of BB170 
reporter. 
Here the linear range of the BB170 
bioassay AI-2 luminescent reporter is 
shown. Values shown are the result of 
three sample averaged, with standard 
deviation displayed, but only visible in 
the 40µM concentration. The linear best-
fit formula is shown with the R2 value. 
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Both LsrK-Tyr and LsrK-Gln were tested for activity in a final solution of 200µL 
with 20 uM AI-2 and 30 uM ATP incubated at 37 °C with shaking for up to 2 
hours. Varying picomoles of LsrK, from 0 to 200, were added as indicated by the 
second row of the chart in Figure 10. Both charts A and B are broken into three 
sets of data for the three time-points, 0.5 hours, 1 hour and 2 hours. For each of 
these time-points triplicate samples from a control of 0 picomoles of enzyme and 
200, 100, 50 and 25 picomoles of enzyme were taken. In A, the first five 
columns/bars show the AI-2 activity after the samples were incubated for half an 
hour with LsrK-Gln, here it can be seen that with 200 picomoles present there is 
a significant decrease in AI-2 activity as indicated by a Student’s T-test p-value 
less than 0.0008. In addition, both 100 and 50 picomoles also demonstrated a 
statistically significant decrease in AI-2 activity. 25 picomoles of LsrK-Gln did not 
produce a statistically significant drop in AI-2 activity for any time point. As shown 
in Figure 10B, LsrK-Tyr demonstrated a significant decrease after just half an 
Figure 10. Modified LsrK activity. 
Activity of both forms of LsrK was demonstrated over time with varying amounts of enzyme. Chart 
A is LsrK-Gln, and chart B is LsrK-Tyr. Aliquots of three biological samples of each enzyme 
amount were taken at the stated times, and were subsequently measured for AI-2 Activity using 
the BB170 assay. Each bar is the result of the average of the three samples with standard 
deviation shown by error bars. P-values are calculated using a Student’s T-Test, two-tailed, type 




hour for all samples (200, 100, 50 and 25 picomoles). Unfortunately the structure 
of LsrK has not yet been published so the specific reason for the disparity in 
activity of the two forms is difficult to determine. It is suggested that the glutamine 
tag disrupts folding, which could be due to use of a shorter linker as was 
necessary to overcome cloning challenges, or the potentially protonated amino 
group of the glutamine. Ultimately, as a result of the better performance in 
reducing AI-2 activity, it was decided to proceed with additional experiments with 
LsrK-Tyr only.  
 
Bound LsrK-Tyr activity was determined initially by binding the enzyme to a 
chitosan film. The pentatyrosine tag on the C-terminus of the LsrK-Tyr was 
specifically added for binding of the protein to an amine-rich surface, in this case, 
chitosan. The tyrosine residues are converted to reactive o-quinone residues by 
tyrosinase which can then bind to the amine groups of chitosan as illustrated in 
Figure 11A. This method was chosen based on success in maintaining activity in 




Figure 11B includes a chart of the fluorescence as measured by a plate reader 
and illustrations of the conditions being measured. Initially known quantities of 
fluorescently labeled LsrK-Tyr were incubated with tyrosinase in wells of a 96-
well plate that had a chitosan film in the bottom as illustrated in the yellow well. 
Figure 11: LsrKTyr bound to chitosan film 
As illustrated in A, fluorescently-labeled LsrK-Tyr was incubated with tyrosinase so that the 
tyrosine residue was converted to o-quinone for binding to the amine group on chitosan. This was 
completed in a 96-well plate as illustrated to the right of the graph in B. The graph is the result of 
fluorescent readings, 3 samples of each quantity, taken at the completion of incubation (orange) 
and again after two washes (blue), the points are the result of the average with provided standard 
deviation. The grey line is a standard curve of labeled enzyme, and the corresponding linear 
best-fit line and R2 are for this standard. 
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During incubation, a fluorescence measurement was taken as represented by the 
yellow dots on the chart for each amount of labeled LsrK-Tyr, where the dots are 
the average of three samples with error bars representing the standard deviation 
of these samples. After incubation the wells were washed and another reading 
was taken of the same wells as represented by the Post-Wash illustration and 
represented by the blue dots on the chart. Again these dots are the average of 
three samples with error bars reflecting the standard deviation. At the same time 
as the washed samples were measured, the fluorescence of samples with known 
quantities of labeled LsrK-Tyr were measured to create a standard curve 
represented by the grey dots and linear best fit indicated on the chart in Figure 
11B. The average of three samples (100, 150, 200 picomoles initially) was 
calculated to be 300 raw fluorescence units, plugging this into the standard curve 
the experimental amount bound was determined to be 13.66 picomoles. The 
experimental result is nearly an order of magnitude larger than the amount of 
LsrK-Tyr calculated to be bound based on enzyme size, 1.9 picomoles. This 
discrepancy may indicate that an area larger than the surface of the well was 
available. It is possible that labeled LsrK-Tyr could bind in the matrix of chitosan, 
rather than just the flat surface. Adding approximately seven-times more LsrK 
molecules to the chitosan matrix to match experimental results, would mean that 
the enzyme would only penetrate a maximum 0.1% the thickness of the chitosan, 
based on previous calculations and assuming layers without packing.  
 In addition to the samples with tyrosinase there were three samples that were 
incubated without tyrosinase, and then washed in the same manner as the other 
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samples. The fluorescence from these samples is seen on the right side of the 
chart in Figure 11B and represented by the larger dots labeled “No Tyrosinase”. 
It does appear that more enzyme is bound non-covalently/nonspecifically as 
indicated by this “No Tyrosinase” sample. With a pI of 5.45, and the enzyme 
incubated in HEPES pH 7 this would make the enzyme relatively negatively 
charged. Even though the chitosan is neutralized as a film the amine groups may 
still bind to this negatively charged enzyme. 
Having verified successful binding, kinase activity was verified two ways, both by 
measuring the resultant amount of ATP and the resultant AI-2 activity. Figure 12 
illustrates the kinase activity of LsrK-Tyr in phosphorylation of AI-2 to AI-2P by 
bound LsrK-Tyr and ATP, and shows the results of the ATP and BB170 
luminescence assays. All samples contain 20 µM AI-2 and 30 µM ATP in LB. In 
Figure 12A the ATP Assay is used to verify LsrK-Tyr activity when bound and 
unbound. The reaction which produces luminescence is found above the chart. 
All conditions in the chart have dried and neutralized chitosan and are the result 
of the average of three samples of each condition with the standard deviation 
provided as error bars. From left to right there is first the sample without LsrK-
Tyr, then one with tyrosinase which was incubated and washed. The next four 
bars are the experimental conditions which all demonstrated a statistically 
significant decrease in ATP concentration compared to the tyrosinase or no 
tyrosinase controls as appropriate. Here it is evident that the covalently bound 
LsrK-Tyr (fourth bar from left), and non-covalent/non-specific binding of LsrK-Tyr 
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(third bar from left) are both active and demonstrate a statistically significant 
decrease in ATP concentration compared with controls.  
In Figure 12 the same samples were evaluated using the BB170 bioassay which 
determines relative AI-2 activity. The samples have been laid out in the same 
order and here it can be seen that the non-covalent/non-specifically bound LsrK-
Tyr, when compared with the tyrosinase-free sample also demonstrates a 
statistically significant decrease in AI-2 activity. The presence of tyrosinase even 
after washing, likely also non-specifically bound to chitosan also seems to reduce 
AI-2 activity or have an effect on the BB170 assay. It is noted that tyrosinase only 
seems to have this effect when incubated in LB, as a similar effect was not seen 
when incubated in PBS (data not provided).  
Figure 12: Activity of bound LsrK-Tyr 
Here the activity of bound LsrK-Tyr was verified using two methods. In A the amount of remaining 
ATP is measured, where luminescence is produced as illustrated by the figure above the chart. In 
B, the BB170 bioassay is used to provide information on relative AI-2 activity, again using the 
production of luminescence as illustrated above the chart. In both, the values are the average of 
three samples and dried and neutralized chitosan is present in all samples. P-values are 




Next, the reporter cells were used to verity the activity of bound LsrK-Tyr. In 
Figure 13A is an illustration of the cellular logic used to produce fluorescence 
with this system and Figure 13B demonstrates the direct relationship between an 
increase in AI-2 concentration and percent reporter cells fluorescing.  
 
At this point a robust multi-lamellar capsule with an alginate core and alternating 
layers of chitosan-alginate-chitosan was fabricated as a proof of concept for 
binding LsrK-Tyr to a chitosan-coated capsule. The capsule, with LsrK-Tyr bound 
with tyrosinase, was placed in a well and a solution of media containing E. coli 
CT104 OD600 0.4 with ATP and varying concentrations of AI-2 in LB media was 
added to demonstrate LsrK5’-1 phosphorylation of AI-2, as illustrated in Figure 
14A. Results as measured by flow cytometry (FACS) are in Figure 14B. Here it is 
Figure 13: Linear range of fluorescent AI-2 reporter 
The reporter cell developed by Tsao et al is used, which works as illustrated in panel A. In panel 
B, the average percent fluorescing cells of three sample (out of 50,000 as counted by flow 
cytometry) is presented vs the concentration of AI-2 to which the cells were exposed. 
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clear that the wells with capsules have less fluoresce with a statistically 
significant margin. It has previously been shown that increasing concentrations of 
AI-2 results in increasing amounts of biofilm formation across several E. coli 
strains, with significant increases in biofilm formation occurs bewteen 3.2 and 11 
µM AI-232. As the linear relationship between AI-2 concentration and percent 
cells fluorescing was previously shown, and the sample initially at 20 µM was 
reduced by over 80%, it is logical to assume that the AI-2 concentration has been 
reduced to less than 5 µM. This concentration of less than 5 µM AI-2 was 
demonstrated to have lead to less biofilm formation than higher concentrations 
(11 µM) and therefore would this reduction in AI-2 concentratioin by LsrK-Tyr 
bound to a capsule would lead to less biofilm formation32.   
Figure 14: Quorum quenching with capsules 
The concept capsule composed of an alginate core with alternating layers of chitosan and 
alginate was used to verify that LsrK could be bound to a surface layer of chitosan on a capsule 
and remain active according to the reaction in A. In B, the percent of CT104 reporter cells 
fluorescing 10 hours after the introduction of AI-2 and ATP was determined using FACS. Chart 
values are based on three samples of 50,000 cells and p-values were found using a Student’s T-
test one-tailed distribution and two-sample unequal variance:  * < 0.03, ** < 0.008. 
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The next step was to implement a capsule capable of delivering the primary 
substrate, ATP. These capsules were specifically designed for ease of 
construction, requiring only a syringe, needle and stir-plate, and to be robust to 
withstand bacterial growth conditions in addition to being able to deliver ATP. A 
uni-lamellar capsule was constructed capable of maintaining integrity during 
bacterial growth conditions (10+ hours, 37 °C, 250 rpm, LB media) as described 
in the methods section.  
Labeled LsrK-Tyr was again used to verify binding to the capsule as can be seen 
in Figure 16. When confocal imagery showed binding to the outer layer (B3) 
capsules were measured to determine surface area and, ultimately, calculate the 
amount of bound LsrK-Tyr to the outer surface. Using the average measured 
diameter of a capsule, 2.75 mm, the surface area of a capsule is 0.24 cm2, and 
the amount of bound LsrK-Tyr, 1.4 picomoles, assuming 78% coverage as with 
the chitosan film. Fluorescence measurements of capsules in the plate reader 
revealed that capsule fluorescence was not statistically different than the well, as 
seen in Figure 15. This was anticipated, as efforts were made to employ similar 
amounts of protein in the wells as in the capsules, based on similar surface 
areas. This may indicate higher amount of LsrK-Tyr binds per surface area of the 
capsule (57 picomoles/cm2) vs the well (43 picomoles/cm2). Even when 
Figure 15: LsrK-Tyr binding: Well vs Capsule.  
Here the raw fluorescence as produced by LsrK-Tyr 
bound to the bottom of a well of a 96-well plate and to 
a capsule after washing is shown. The bars are 
representative of the average of three samples with 
the error bars representing the standard deviation. 
Here it is clear that the amount bound is similar in both 
conditions as measured by fluorescence. 
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considering this slightly higher binding density, the LsrK-Tyr layer size, compared 
with the capsule shell is similar that of the chitosan in the well, less than 0.1% the 
depth of the chitosan layer. 
 
Initially, uni-lamellar capsules without ATP were verified for quenching capability. 
These capsules were placed in the wells of a 24-well plate and media containing 
E. coli CT104 OD600 0.4 was added with varying concentrations of AI-2 in LB 
media and incubated at 37 °C for 8 hours with shaking. After incubation, the 
capsules were observed to still be intact, demonstrating ability to maintain 
structure in bacterial growth environment.  
Aliquots of each sample were taken and FACS was again used to obtain a count 
of per-cell fluorescence for the uni-lamellar capsules. Figure 17 contains the 
results of averaging FACS results from three samples of each condition. The 
statistical significance seen between the positive controls of AI-2 and CT104 cells 
in solution with capsules without LsrK-Tyr and those with capsules with LsrK-Tyr 
bound demonstrates that AI-2 concentration is decreased by over 98% by LsrK-
Figure 16: LsrK binding to quenching 
capsules 
The images of the capsules as taken 
by a stereo microscope (B1, B3, B4) 
are shown in Figure B. Here red 
fluorescently-labeled LsrK is bound 
to a capsule with green fluorophores 
mixed in the alginate. A confocal 
microscope was used to produce the 
image which shows the labeled LsrK 




Tyr bound on the capsule in common bacterial growth conditions. This data 
indicates that the LsrK-Tyr functionalized capsule is capable of reducing the AI-2 
communication signal for a population of E. coli cells such that on average no 
cells were fluorescing, indicating sub-micromicromolar concentrations and 
therefore leading to less biofilm formation32.  
 
 
Figure 17: Uni-laminar capsules with in vitro produced AI-2 
Panel A of the figure illustrates the reaction which is taking place. Here a capsule as 
described previously, without ATP in the core, is introduced to a solution containing ATP and 
AI-2. The LsrK-Tyr bound to the outside of the capsule phosphorylates the AI-2 to AI-2P, so 
that the reporting cells, CT104, no longer recognize the communication signal. A quantitative 
measure of this quenching is provided in the chart, where each bar is the average of three 
50,000 cell samples. These show the percent of fluorescing CT104 reporter cells as counted 




Capsules with 222 µM ATP mixed with alginate during formation were analyzed 
to verify that the ATP was diffusing out of the capsule. Twenty-four single-layer 
ATP/alginate-chitosan capsules were divided across three wells of a 6-well plate 
so that eight capsules were in each well and 5 mL of LB was added to the 
capsules. The capsules were then shaken on a rotating shaker at 37 °C and 
aliquots of the LB were removed at various time intervals until 120 minutes had 
elapsed. At the completion of a 120 minutes the ATP assay was used, with a 
standard curve, to determine the resultant concentration of ATP in solution at 
each time point. A graph of the data is found in Figure 18, demonstrating that the 
ATP does diffuse out of the capsule and equilibrium was reached within 50 
minutes of the start of shaking. (Additional information and calculations on ATP 
diffusion are found in Appendix A.)  
To this point, AI-2 produced in vitro was used in known quantities to reduce 
variability of production by cellular populations. To more fully prove the 
functionality of the capsules, media from a culture of BL-21, an AI-2 producing E. 
Figure 18: ATP diffusion out of 
capsules 
Here is provided the diffusion of 
ATP out of capsules over time. 8 
capsules were placed in 2mL of 
LB and incubated at 37 °C with 
shaking. Aliquots were removed 
at indicated times and measured 
for ATP activity using Kinase-
Glo® Plus.,ATP concentration 




coli, and the reporting E. coli, CT104, was used. The AI-2 producing cells were 
grown to OD600 of 1.0 in LB media, and the cells were removed by syringe 
filtering the solution with a 0.22µm filter. This solution was then diluted with LB 
(2:1) and incubated with the capsules for 10 minutes at 37 °C. After incubation an 
equal amount of reporting E. coli was added to the solution and capsules and 
incubated for 8 hours with shaking at 37 °C. After 8 hours aliquots were taken 
and diluted with PBS for flow cytometry. Figure 19A is an illustration of this 
experiment and Figure 19B are the flow cytometry (FACS) results of the average 
percent of fluorescing cells of three separate samples. All samples have a 
capsule, however, the second, fourth and sixth columns from the left have a 
capsule with covalently bound LsrK-Tyr. The first two columns reflect reporter 
cells fluorescence and decrease in fluorescence when using a known quantity of 
AI-2 and ATP in addition to that found in the capsule. The last four columns 
represent the reporter cell fluorescence as a result of the conditioned media from 
the AI-2-producing cells and subsequent decrease in percent cells fluorescing 
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when a capsule with LsrK-Tyr is present as represented by columns four and six. 
In columns three and four, a known quantity of ATP was added exogenously, in 
addition to that contained within the capsule. From the results shown in Figure 19 
it is clear the capsule composed of ATP/alginate and chitosan with covalently 
bound LsrK-Tyr is capable of reducing the concentration of AI-2 as measured by 
the AI-2 reporter cells, CT104. These results specifically indicate a nearly 
complete elimination of AI-2 in solution.  
3.4 Conclusion & Discussion 
It has been demonstrated in this work that both modified forms of LsrK are active 
in solution. The tyrosine-tagged LsrK was successfully attached to both a 
chitosan film and a capsule, demonstrating quenching in both cases. 
Immobilization of this enzyme, capable of quenching the ‘universal’ quorum 
sensing molecule, on a surface using free amine groups is a significant 
Figure 19: Functionalized quenching capsules 
In A the capsule with ATP inside and LsrK-Tyr on the outside is illustrated phosphorylating AI-2 
which has been produced by the BL21 cell-line of E. coli. This phosphorylated AI-2 is not 
recognized by the CT104 reporter strain, preventing it from fluorescing red. The decreased red 
fluorescence as counted by flow cytometry is shown in B, each bar the average of three samples. 
Here it is shown that very few cells fluoresce in the presence of the functionalized capsule. P-
values are calculated using a Student’s T-Test, two-tailed, type 2; ** < 0.008, *** < 0.0008.  
60 
 
advancement. There are already several examples of surfaces being amine-
modified211,212 so the enzyme as it exists could be added to this materials to 
provide AI-2 quorum quenching capabilities to a wide variety of environments.  
The immobilization of the kinase LsrK-Tyr on both a flat surface and capsule 
demonstrate a new delivery mechanism for this powerful kinase. In addition, 
while kinases are notoriously unstable it appears that binding the enzyme to a 
surface provides some stability. Specifically, while the enzyme, even in high 
concentrations of glycerol loses effectivity after a single freeze-thaw-freeze cycle 
(not shown), the bound enzyme was found here to maintain activity after 
incubation for one hour at 37 °C with shaking as seen in Figure 17 Figure 19). 
Should binding, both covalently and non-covalently, increase stability of LsrK-Tyr 
it would broaden the ‘real-world’ applicability of using LsrK-Tyr for quenching AI-
2. As a result, it would be prudent to study the stability of the bound enzyme. 
The amount of ATP in the capsule used herein is limited and diffuses rapidly. 
Other nanoparticles, composed of chitosan, have previously been shown to have 
a slower release of ATP over 24 hours213. These nanoparticles are also 
significantly smaller, which provides more surface area in the same volume for 
additional delivery of LsrK-Tyr in addition to the more controlled release of ATP. 
The more controlled release of ATP would allow more of this primary substrate 
be added to the capsules initially, and when combined with the capability to both 
deliver more of the LsrK-Tyr enzyme could result in additional reduction of AI-2 
concentration over a longer period of time.  
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While the amount of ATP delivered in the capsule is limited, and for surface-
bound LsrK, no ATP is provide with the enzyme, however this may not be a 
significant issue. Extracellular ATP is found in supernatant of cultures of E. coli, 
Salmonella, Klebsiella, Acinetobacter, Pseudomonas, and Staphylococcus in 
concentrations of 20 – 600 nM, indicating both delivery mechanisms may have 
some effectivity in environments with bacteria 214,215. In addition, it was found that 
E. coli and Salmonella had increased survival in the presence of ATP-
supplemented culture216. As a result, this immobilized enzyme may not only 
reduce biofilm formation and toxicity by quenching AI-2, but also by consuming 
ATP in the process.  
As both chitosan and alginate are already used in wound dressing13 14, 
functionalizing these substances with LsrK provides an active barrier in the 
prevention of biofilm formation. Capsules could be placed in wounds to prevent 
biofilm formation and infection, and surfaces could be coated with the enzyme for 
oral applications. And because the materials used, chitosan and alginate, are 
already used in healthcare, there are procedures for sterilization that also 




4 CHAPTER 4: MODIFICATION AND BIOPOLYMER 
ATTACHMENT OF A VERSATILE LACTONASE FOR  
4.1 Introduction 
The World Health Organization has identified antibiotic resistance as “… one of 
the biggest threats to global health today. It can affect anyone, of any age, in any 
country.”219 Despite this large global health concern, few new antibiotics are 
being developed, and current antibiotics are losing effectivity. As a result, new 
methods of combating harmful bacterial effects are being explored, including 
affecting bacterial communication pathways as a means of effecting bacterial 
biofilm formation and toxicity. There are several classes of bacterial 
communication molecules that can be targeted, including homoserine lactones, 
N-Acyl homoserine lactones (AHLs), or AI-1, which are used by Gram-negative 
bacteria including Pseudomonas aeruginosa. Enzymes that hydrolyze the ester 
bond of lactones, lactonases, have been shown to render the communication 
molecule unrecognizable to cells, disrupting the communication pathway. Cell 
population phenotypes can be modified by interfering with bacterial 
communication, providing a non-invasive way of altering bacterial behavior 
including reducing toxicity 27. Quenching AHL communication is complicated by 
the fact that many different molecules, used by different bacteria are contained 
within the class of AHL, unlike AI-2 which is more universal. As a result, it is 
desirable to choose a lactonase that is more promiscuous, meaning that a single 
enzyme is capable of hydrolyzing several different AHLs. 
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The WHO has also identified chemicals of major public health concern. This list 
of ten chemicals includes hazardous pesticides, which are so pervasive the WHO 
established their Pesticide Evaluation Scheme (WHOPES) to monitor pesticide 
safety220. Organophosphates (OP), discovered during the development of nerve 
gas, are commonly used in pesticides and have known neurologic effects. OPs 
inhibit acetyl cholinesterase activity, which leads to decreased nerve function221 
and have been shown to cause long-term developmental and behavioral 
neurological effects 222,223. OPs have also been shown to affect liver, respiratory 
and cardiac function 223. As a result, phosphotriesterases (PTEs), which 
neutralize organophosphates by hydrolysis of organophosphate esters 224, are of 
particular interest for treatment both prophylactically and after exposure225,226. 
Because hydrolysis is required in ‘neutralizing’ both molecules, an increasing 
number of studies have been conducted on enzymes which have both lactonase 
and PTE activity225,227. 
Based on these requirements the enzyme SsoPox, named such based on 
organism of origin (Sulfolobus solfactircus, Sso) and its initial identification as a 
paraoxonase (Pox) was chosen as the lactonase for incorporation into a 
functionalized system. SsoPox, from hyperthermophilic Sulfolobus solfataricus62, 
has previously been shown to exhibit promiscuous lactonase activity with a 
preference toward AHLs with 8 - 10 carbon aliphatic chains and oxo-lactones 
with shorter chains63. It has been produced in E. coli and has as structure where 
the active site is opposite the N- and C- termini, as seen in Figure 20, indicating 
that modifications to these may not affect activity SsoPox has also been studied 
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for its ability to hydrolyze organophosphates228,229 and homoserine lactones63. 
The structure of SsoPox is of particular interest as it enables high thermostability 
62, relatively non-specific hydrolysis230 and the location of the N-and C- termini – 
opposite the dimer binding site and loop 8 active site 63 – providing the potential 
to modify the enzyme for purification and attachment. 
In this work, three tags have been added to two modified SsoPox proteins, a 
hexa-histidine tag has been added to the N-terminus in both and a penta-tyrosine 
tag or quaternary glutamine tag added to the C-terminus. The hexa-histidine tag 
provides a simpler method of purification – previously heating, H/F-PLC, NaCl 
gradient and dialysis has been used in SsoPox purification 228,231. In addition to 
the hexa-histidine tag, tyrosine and glutamine tags have been added to the C-
terminus to facilitate covalent binding to the biopolymer chitosan204,232. These 
were specifically chosen based on success in maintaining activity in other 
proteins after attachment to chitosan204 and more wide-spread use of free-amine 
binding for functionalizing surfaces212.  
Figure 20: Cartoon of SsoPox  
This cartoon, generated using the 
expasy swiss-model and then visualized 
using Chimera from UCSF, illustrates 
the orientation of the N- and C-terminus 
as well as highlights the colbalt ions at 
the location of the active site.   
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Attaching SsoPox to the biopolymer chitosan, which is commonly used for drug 
delivery and wound healing applications233, will provide new ways of delivering 
lactonase and potentially, organophosphate hydrolysis activity. Here lactonase 
activity is verified for the AI-1, OdDHL/3-oxo-C12HSL/OdDHL, which stimulates 
inflammation in mammalian cells and promotes production of the toxin pycyonin 
in P. aeruginosa94.  
4.2 Materials & Methods 
 
The SsoPox genetic sequence was optimized for E. coli using the IDT codon 
optimization tool and the gBlock and primers for insertion into pET200 plasmid 
were ordered from IDT (Coralville, IA, USA). The primer sequences are in Table 
2 and the gBlock sequence is found in Appendix 2.  
To construct the tyrosine-tagged SsoPox, the gBlock was amplified using F-
SsoPox and SsoPoxR-Tyr. The purified PCR product was digested with SacI and 
NheI for sticky-end ligation into the pET200 backbone to create pHSsoPoxTyr. 
To add the glutamine tag the pHSsoPoxTyr plasmid was digested with NheI and 
SacI. The SsoPox gene was amplified with Q5 (NEB, Ipswich, MA) with the same 
forward primer as used previously and the new reverse primer, SsoPoxR-Gln 
was used to add the glutamine tag. This PCR product was digested and ligated 
into the backbone previously digested. The sequence of the resultant plasmids 
(pHSsoPoxT and pSsoPoxG) were verified by Genewiz (Frederick, MD). After 
transformation into E. coli BL21(DE3) pLysS cells the enzymes SsoPox-Tyr (MW: 




Table 2. Primers for SsoPox-X plasmid construction 
 
 
Cells were inoculated from frozen stock and grown overnight in Luria Burtania, 
LB (Fisher, Pittsburgh, PA), and 50µM kanamycin at 37 ºC, 250 rpm. These cells 
were re-inoculated to OD600 0.05 in 200mL ZYP-5052 media without metals mix 
234. Cells were initially grown at 37 ºC with shaking (250 rpm) until the culture 
reached OD600 1.0 (3.5 – 4 hrs). The culture was then subjected to cold-shock – 
swirled in ice-water for approximately 5 minutes – during which 0.2 mM CoCl2 
was added as was done previously 229. Cell growth continued at room 
temperature (~24 ºC) for 20 hours with shaking (250 rpm). Cells were then 
pelleted (10000g, 4 ºC, 10 min), and re-suspended in a lysis buffer similar to that 
used by Hiblot et al (50 mM HEPES pH 8, 150 mM NaCl, 0.2 mM CoCl2, 0.1 mM 
PMSF and 20 mM MgSO4)229 and frozen at -80 °C. A Fisher Scientific 550 Sonic 
Membrator at power 3.5 for 10 minutes 0.5 on/0.5off was used to disrupt the 




Protein purification was achieved using a GE Healthcare Life Sciences HiTrapTM 
Chelating HP Column, and the hexa-histidine-tag on the SsoPox-X protein. Two 
columns were used in this work: one loaded with Ni2+, and the other loaded with 
Co2+. First, IMAC Buffer (50mM NaPO4, 1.25M NaCl, pH 7.4) was used for both 
columns, then the Activity Buffer described by Hiblot et al229 was used, both with 
increasing concentrations of imidazole after protein loading to determine optimal 
purification conditions. The most pure sample of SsoPox-Tyr/Gln underwent 
dialysis in Activity Buffer with gentle stirring at 4 ºC until final imidazole 
concentration was less than 100nM. The dialyzed enzyme concentration was 
measured using a nanodrop and appropriate MW/Extinction coefficients 
(SsoPox-Tyr: 39.7kDa/37.4k, SsoPox-Gln: 38.7kDa/30k) and stored in 10% 
sterilized glycerol at -20 °C.  
 
Construction of an AI-1 reporter was completed using constructs from Lindsay et 
al235, ‘standard parts’, a constitutive promoter developed in-lab and the pET21a 
backbone. This reporter, using genes and proteins from P. aeruginosa, produces 
green fluorescent protein in the presence of the AI-1, OdDHL. All primers were 
obtained from IDT (Coralville, Iowa). Plasmid maps of the reporters are found in 
Appendix B.  
The first plasmid constructed, pAHL-Reporter_Red-Green, constitutively 
expresses dsRedExpress2 and P. aeruginosa LasR. LasR binds to OdDHL to 
form the OdDHL-LasR complex, which binds to the P. aeruginosa DNA binding 
site also incorporated into this plasmid. This DNA binding site is a positive 
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transcriptional regulator that is activated upon binding of the OdDHL-LasR 
complex to the DNA, which activates transcription of sfGFP to signal the 
presence of OdDHL. This plasmid was transformed into the E. coli strain W3110 
LuxS- which does not produce AI-2. Subsequently, modifications were made to 
the plasmid using the restriction enzyme BstEII to cut 200bps from the center of 
dsRedExpress2 from pAHL-Reporter_Red-Green, rendering the quaternary 
protein inactive, but maintaining LasR production, and forming a new plasmid: 
pAHL-Reporter_Green. The new plasmid was transformed into Top10 cells. Both 
reporter cells were stored as frozen stock and inoculated from frozen stock the 
day before use.  
 
The modified SsoPox enzyme activity was verified by two methods that used 
reporter cells to indicate the presence of AHL N-dodecanoyl-L-homoserine 
lactone (OdDHL), obtained from Cayman Chemical (Ann Arbor, MI). 225µM and 
20µM concentrations of OdDHL were used in experiments, with samples diluted 
as required by the biological reporter cells. The first reporter cell, a luminescent 
reporter, developed and provided by the Ahmer Lab 235 provides a quantitative 
indication of OdDHL activity in the nanomolar range (10-9-10-7), requiring samples 
to be diluted. The second, developed here, uses the same P. aeruginosa LasR 
and DNA binding site, but includes fluorescent reporter that provided a new 
method of measuring the response.  
Incubation was completed in a multi-well plate with positive controls and negative 
controls contained in the same plate as the experimental conditions. As a result, 
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all samples were incubated for the same times and temperatures and completed 
in triplicate. Sample aliquots were removed and diluted for both luminescent and 
fluorescent reporters. 
The luminescent reporter was inoculated and grown overnight in LB with 50µM 
kanamycin and 5µM tetracycline at 37 ºC, 250 rpm. Cells from the overnight 
culture were diluted 1:2500uL in LB with 50µM kanamycin and 5µM Tetracycline 
and 180µL of diluted cells were added to 20µL of the diluted incubation sample in 
a 5 mL test tube or 90 µL of cells were added to 10µL of diluted sample in a 96-
well white plate. The sample was incubated at 30 ºC, 250 rpm for several hours 
and luminescence was measured using a GloMax®-Multi Jr (Promega) or 
Synergy HT plate reader.  
The fluorescent reporter cells were also inoculated and grown overnight in LB 
(100µM ampicillin/carbenicillin at 37 ºC, 250 rpm). These cells were re-inoculated 
and grown to OD600 0.4 and again 180 µL of cell culture was added to 20 µL of 
the diluted incubation sample in a 5 mL test tube or 90 µL of cells were added to 
10 µL of diluted sample in a 96-well white plate. This culture was incubated at 37 
ºC, 250 rpm, for 3 hours and the percent of fluorescing cells was counted by flow 
cytometry. 
 
SsoPox-Tyr was constructed with a penta-tyrosine tag on the C-terminus for the 
binding of the protein to a surface. Methods similar to Wu et al204 were used, 
where 1.5% chitosan (Sigma, St. Louis, MO) was dried overnight by vacuum 
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incubation at 30 °C in a 96-well plate, then neutralized with 1M NaOH and rinsed 
with HEPES pH 7.0 (Sigma, St. Louis, MO). SsoPox-Tyr was added in varying 
concentrations to 350u of tyrosinase (Sigma, St. Louis, MO) and HEPES pH 7.0 
added to a final volume of 100 µL per well. After allowing the tyrosinase and 
SsoPox-Tyr to incubate for 1 hour at 37 °C with shaking, each well was rinsed 
with HEPES pH 7.0 three times, as was done in previously. Binding to chitosan 
films and capsules was verified by labeling SsoPox-Tyr with DyLightTM 
Sulfhydryl-Reactive Dye (ThermoFisher Scientific, Grand Island, NY). Bound His-
SsoPox-Tyr activity was verified by binding the protein as described, then 
repeating the methods described previously for protein activity.  
 
SsoPox-Gln was constructed with a quaternary-tyrosine tag on the C-terminus for 
the binding of the protein to a surface. Methods similar to Bhokisham et al232,236 
were used, where the chitosan film was prepared as previously described. Here 
a 60 µL 1 mM K-Y-K peptide (Sigma, St. Louis, MO) in pH 7.0 HEPES was 
combined with 350u of tyrosinase and HEPES pH 7.0 was added to a total final 
volume of 100 µL. After allowing the peptide and to incubate for 1 hour at 37 °C 
with shaking, each well was rinsed with HEPES pH 7.0 three times, as was done 
in previously.  
Next, the SsoPox-Gln enzyme was bound to the peptide using microbial 
transglutaminase (MTG) (Sigma, St. Louis, MO). Here MTG was prepared by 
making a 5% w/v solution in 10mL of pH 7.0 HEPES and filtering this solution 
with a 0.22µ filter. Final concentration of the MTG solution was measured using a 
71 
 
nanodrop. 60 µM of MTG was used to bind varying concentrations of SsoPox-Gln 
to the peptide with HEPES pH 7.0 supplementing the solution to 100 µL; again 
incubation of binding occurred for 1 hour at 37 °C with shaking. Binding to 
chitosan films and capsules was again verified by labeling SsoPox-Gln with 
DyLightTM Sulfhydryl-Reactive Dye. Bound SsoPox-Gln activity was verified by 
binding the protein as described, then repeating the methods described 
previously for protein activity.  
 
Binding of enzymes to chitosan films and capsules was verified by labeling 
SsoPox with DyLightTM sulfhydryl-reactive dye. The amount of chitosan in the 
bottom of the 96-well plate and surface area of the well was used to calculate 
amount of LsrK-Tyr per surface area of chitosan. The outer diameter (1.375 mm) 
and shell thickness of capsules (0.2 mm) were measured immediately after 
rinsing using an MVX10 MacroView fluorescence stereomicroscope (Olympus, 
Center Valley, PA) as shown in Figure 31. This information was used to calculate 
the average surface area of the capsule (23.76 mm2) and subsequent amount of 
bound SsoPox based on the surface area of a well of a 96-well plate (0.32 cm2).  
The chitosan film in the bottom of a 96-well plate was used initially to verify 
binding and estimate binding density. Labeled SsoPox was incubated with the 
dried chitosan in a 96-well plate (surface area of 0.32 cm2) and a plate reader 
was used to take fluorescent readings during incubation and after rinsing. Using 
these post-rinse fluorescent readings and a standard curve the amount bound 
was calculated as shown in Figure 21  
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In addition, the maximum amount of enzyme per surface area was calculated 
using the molecular weight of SsoPox (38.7, 39.6kDa) for each well. For these 
calculations it is assumed SsoPox is a soluble, globular protein, so the partial 
specific volume is 0.74 cm3/g207. Multiplying this by the molecular weight and 
dividing by molecules per mole yields a cubic centimeter estimate of volume per 
molecule and subsequent radius of 2.25x10-7 cm for SsoPox-Tyr and 2.24x10-7 
cm for SsoPox-Gln. Assuming a spherical molecule, the surface area this sphere 
would cover can be determined, 16x10-13 cm2 for both enzymes and this 
becomes a circle packing problem onto the bottom of a 96-well plate with an area 
of 0.32 cm2. While formulas for efficient packing of up to 20 circles have been 
found208, packing additional circles becomes a complex coding optimization 
problem. As a result, for purposes of this work, the square packing hexagon 
model, also shown as 7 circles within a circle as seen in Figure 22, is used to 
estimate ratio of surface area covered. Here the inner circles are the same radius 
as that of the enzyme, r, 2.25x10-7 or 2.26 x10-7 cm, and the radius of the outer is 
3*r. As the area of a circle is πr2, this means approximately 7/9 or 78% of the 
surface area is covered. This is the same percentage that was found using an 
Figure 21. SsoPox-Gln Binding 
Measurements in the chart were completed 
in 96-well plate, illustrated to the right of 
the graph and are the average of 3 
samples of each quantity, taken at the 
completion of incubation (orange) and after 
washing (purple). Error bars represent 
standard deviation. The grey line is a 
standard curve of labeled enzyme, and the 
corresponding linear best-fit line and R2 are 
for this standard. 
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online calculator2 and extrapolating, where 1.15x1012 molecules, or 1.9 
picomoles of SsoPox, covering an area of 0.25 cm2 were found to fit on the 
bottom surface of a 96-well plate, 7.6 picomoles/ cm2. This calculation of 
coverage only considers the estimated size of the enzyme, and does not 
consider additional distance that may occur between enzymes due to repulsion 
of the similarly charged molecules.  
Assuming a single layer of enzyme, this layer is 4.5x10-7 cm thick, while the 
chitosan layer in the well is approximately 0.05 mm thick, meaning the enzyme 
layer is less than 0.1% the size of the chitosan layer. 
4.3 Results 
 
Here, for the first time SsoPox was successfully modified with a histidine tag, 
making it possible to purify the enzyme using this tag. The first modified SsoPox, 
SsoPox-Tyr, was initially purified a Ni2+ column with each of IMAC and the 
Activity buffer. While the IMAC elution yielded some enzyme, Figure 23B, the 
Activity Buffer did not due to ionic ‘competition’ between the Ni2+ column and the 
Co2+ in the buffer. Given this, and that SsoPox is a metallo-enzyme with cobalt as 
                                            
2 http://www.engineeringtoolbox.com/smaller-circles-in-larger-circle-d_1849.html 
Figure 22. Circle Packing 
Here the blue circles represent the enzyme and the green the area 
to be covered.  
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the stabilizing metal ion a Co2+ column was used yielding a clean elution Figure 
23C. The two Western blots for SsoPox-Tyr purification with Ni2+ and Co2+ 
columns are provided in Figure 23B, C. SsoPox-Tyr was rinsed with 20mM and 
60mM imidazole in Activity Buffer before being eluted with 1M imidazole. 
SsoPox-Gln rinsed with 40mM and 100mM imidazole in Activity Buffer before 
being eluted with 300mM imidazole. The SDS-PAGE gel of the elution of each 
variant of the SsoPox enzyme is also shown in Figure 23D with a summary of 
enzyme purification and yields Figure 23A.  
Figure 23: Purified SsoPox-X 
A summary of the construction, purification and yield of the enzymes developed in this work are 
compared to previous work in A. Figures B and C are the results of a Western blot comparing the 
purity of samples when a Nickel (B) vs Cobalt (C) column was used for purification. In both the 
lanes are first a ladder then extracellular sample for Ni2+ and the insoluble and soluble samples 
for each. This is followed by increasing concentrations of imidazole to determine best elution 
concentration and purity of samples. Finally in D the purification of each His-SsoPox-Gln (left of 




All three reporters were verified for a direct response, luminescent or fluorescent, 
to increasing concentrations of the AI-1, OdDHL. In Figure 24 the direct 
relationship between AI-1 concentration and luminescence is shown. This 
standard was repeated for every measure of luminescence when using the 
Synergy HT plate reader.  
 
Similarly, the AI-1 response of the two fluorescent reporters were also measured 
using flow cytometry and a 4-point standard was conducted when measurements 
were taken. In Figure 25 both the overall range and linear range of the reporters 
are shown. The Red-Green reporter did show better consistency between runs, 
as the overall range was comprised of two different days of tests, and this 
reporter provided a better linear best fit. 
Figure 24: Linear range of luminescent AI-1 reporter.  
The cells as developed by Lindsay et al were obtained and used as the primary means of 
determining reduction of AI-1 concentration. Here the linear range of this reporter is 
demonstrated. Luminescence was measured by plate reader. Each point is the average of three 







Using the luminescent reporter, the activity of the two modified forms of SsoPox 
were verified in solution. Both SsoPox-Gln and SsoPox-Tyr were tested for 
activity in a final solution of 100µL with 225 uM OdDHL (AI-1) incubated at 37 °C 
with shaking for up to 4 hours. Varying picomoles of SsoPox, from 0 to 200, were 
added as indicated by the second row of the chart in Figure 26. Both charts A 
and B are broken into three sets of data for the three time-points, 1 hour, 2 hours 
and 4 hours. For each of these time-points triplicate samples from a control of 0 
picomoles of enzyme and 200, 100, 50 and 25 picomoles of enzyme were taken. 
Figure 25: Linear range of fluorescent AI-1 reporter.  
Here, two new reporter cells were used to measure the concentration of AI-1 in solution. They 
are both based on the same plasmid backbone, and placed in different cell-lines. Figures A and 
B are a reporter that only turns green in the presence of AI-1 in the Top10 cell-line. In C and D, 
the Red/Green reporter is constitutively expressing red and turns green in the presence of AI-1. 
This is in a cell line that does not produce AI-2 so could be used in AI-1 and AI-2 quenching 
environments. The data for all four charts are average percent of cells fluorescing of three 
cultures, with standard deviation, which is visible in the linear range in charts B and C. Each 
point is the result of 50,000 cells as counted/measured by flow cytometry. 
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In Figure 26A, the first four columns/bars show the AI-1 activity after the samples 
were incubated for an hour with SsoPox-Gln, here it can be seen that with 200, 
100, 50 and 25 picomoles present there is a significant decrease in AI-1 activity 
as indicated by a Student’s T-test p-value less than 0.0008. The same is true for 
the 2 hour time point, with all experimental samples exhibiting a statistically 
significant decrease in AI-1 activity. At hour four, statistical significance is 
maintained, but p-values are higher due to more variability in the control. As 
shown in Figure 26B, SsoPox-Tyr demonstrated a significant decrease after just 
an hour for 200 and 100 picomole samples, but no statistically significant 
decrease was found when 25 picomoles were present, even after 4 hours.  
The difference between the activity of the two forms of SsoPox could be the 
result of differences in structure of the two attachment tags. As the N- and C- 
terminus are next to one another it is possible that the aromatic rings of the hexa-
histidine tag and tyrosine tag are interfering with one another, and subsequently 
with folding in this area. It is also possible that the linker or aromatic ring of the 
tyrosine residues affect the α-helix which precedes both on the C-terminus.  
Figure 26: AI-1 Quenching with lactonase in solution.  
In A, SsoPox-Gln activity of known quantities was measured over several hours. In B, known 
quantities of SsoPox-Tyr were monitored for activity over several hours. The average of 
triplicates of each sample are shown with standard deviations from samples in a 96-well plate. 
Aliquots of each sample were taken at 1, 2 and 4 hours as indicated. 
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With activity in solution of both variants of SsoPox demonstrated, the next step 
was to verify the ability to bind the two variants to chitosan.  
SsoPox-Tyr binding to chitosan films and capsules was completed using 
SsoPox-Tyr labeled with DyLightTM Sulfhydryl-Reactive Dye. The chitosan film in 
the bottom of a 96-well plate was used initially to verify binding and estimate 
binding density. Labeled SsoPox-Tyr was incubated with the dried chitosan in a 
96-well plate (surface area of .32 cm2) and a plate reader was used to take 
fluorescent readings during incubation (yellow well and dots) and after rinsing 
(purple well and dots) as illustrated in Figure 27B. A fluorescence measurement 
was taken as represented by the dots on the chart for each amount of labeled 
SsoPox-Tyr, where the dots are the average of three samples with error bars 
representing the standard deviation of these samples. After incubation the wells 
were washed and another reading was taken of the same wells as represented 
by the Post-Wash illustration and represented by the blue dots on the chart. 
Again these dots are the average of three samples with error bars reflecting the 
standard deviation. At the same time as the washed samples were measured, 
the fluorescence of samples with known quantities of labeled SsoPox-Tyr were 
measured to create a standard curve represented by the grey dots and linear 
best fit indicated on the chart in Figure 27B.  
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Using the average fluorescence of the samples with 150, and 200 picomoles 
initially, 175, and the standard curve the experimental amount bound was  
determined to be 57 picomoles, which is over an order of magnitude larger than 
that previously calculated based on enzyme size, 1.9 picomoles. This 
discrepancy may indicate that an area larger than the surface of the well was 
Figure 27: SsoPox-Tyr binding to chitosan.  
In A, the binding of SsoPox-Tyr is illustrated using tyrosinase to form an o-quinone on the 
tyrosine residue which binds to the amine groups on chitosan. Figure B is the result of fluorescent 
readings taken at the completion of incubation (yellow) and again after washes (blue).Points are 
the result of the average of 3 samples with provided standard deviation. The grey line is a 




available. It is possible that labeled SsoPox-Tyr could bind in the matrix of 
chitosan, rather than just the flat surface or that the chitosan.  
In addition to the samples with tyrosinase there were three samples that were 
incubated without tyrosinase, and then washed in the same manner as the other 
samples. The fluorescence from these samples is seen on the right side of the 
chart in Figure 27B and represented by the larger dots labeled “No Tyrosinase”. 
It does appear that more enzyme is bound non-covalently/nonspecifically as 
indicated by this “No Tyrosinase” sample. With a pI of 6.28, and the enzyme 
incubated in HEPES pH 7 this would make the enzyme slightly negatively 
charged. Even though the chitosan is neutralized as a film the amine groups may 
still bind to this negatively charged enzyme. 
Similarly, binding of SsoPox-Gln was tested with a fluorescently labeled protein. 
Figure 28A and B illustrate the two-step binding process. Figure 28C is the 
average of three samples as measured by the plate reader incubation of known 
quantities of labeled SsoPox-Gln and then again after washing each well three 
times, with error bars representing the standard deviation of these standards. A 
standard curve was again created using known concentrations of labeled 
SsoPox-Gln and this curve was used to calculate the amount of bound SsoPox-
Gln after washing (12.6 picomoles, using the average of the values measured for 
150 and 200 picomoles). In addition to verifying binding via the two-step process 
for the SsoPox-Gln, samples were incubated without tyrosinase and found to 
remain bound after washing. This is reflected in Figure 28C on the far right 
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labeled “NoTyrosinase” and using the standard curve represents 35 picomoles 
bound. Considering that SsoPox-Gln has the same pI as SsoPox-Tyr it is likely 
that the slightly negatively charged enzyme is binding to the neutralized chitosan. 
As outlined in the methods section the estimated amount bound of both SsoPox-
Tyr and SsoPox-Gln was determined to be 7.6 picomoles/cm2 for each given the 
small difference in radius between the two variations. This took into consideration 
circle packing for a coverage of 78%, and does not consider repulsion of the 
similarly charged molecules. While calculated or theoretical max is often more 
than experimental results, the opposite was found here and there are at least two 
explanations. First, it is likely that the chitosan is not dried perfectly flat, providing 
additional surface area, and secondly, there exists the possibility that enzyme is 
binding within the chitosan matrix, again, to a larger area than that of the bottom 
of the well. Should the case be that the enzyme is binding in the chitosan matrix, 
Figure 28: SsoPox-Gln binding to chitosan.  
In A, the binding of the K-Y-K peptide is illustrated using tyrosinase to form an o-quinone on the 
tyrosine residue which binds to the amine groups on chitosan. Figure B shows the multi-step 
process whereby MTG aids in binding the SsoPox-Gln to the lysine groups of the peptide. Figure 
C is the result of fluorescent readings taken at the completion of incubation (yellow) and again 
after washes (blue). Points are the result of the average of 3 points with provided standard 
deviation. The grey line is a standard curve of labeled enzyme, and the corresponding linear 
best-fit line and R2 are for this standard. 
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adding between seven and thirty-times more SsoPox molecules (to match 
experimental results) would mean that the enzyme would only penetrate 0.1- 
0.3% the thickness of the chitosan, based on a layer of enzyme 4.5 x10-7 cm 
thick. 
Both SsoPox-Tyr and SsoPox-Gln demonstrated successful binding to the 
chitosan surface, with experimental results indicating that the covalently and non-
covalently bound SsoPox-Tyr (57, 110 picomoles) bound in higher quantities 
when compared with SsoPox-Gln (12.6, 35 picomoles). However, previously 
SsoPox-Gln demonstrated more activity in solution so both variations were tested 
for bound enzyme activity. As described, chitosan was bound to the wells of a 
96-well plate and both enzymes were bound within the same plate, with the first 
step of the two-step glutamine binding completed and then both enzymes binding 
at the same time with and tyrosinase. Positive controls of unbound enzyme were 
included to verify the enzymes were active. As can be seen in the first five 
columns of Figure 29A both unbound enzymes are active, with both 
demonstrating statistically significant decreases in AI-1 activity. However, only 
SsoPox-Gln provided a statistically significant decrease in AI-1 concentration as 
seen the last two columns. In Figure 29B it is evident that there is a small 
difference between the two amounts of unbound SsoPox-Gln (200 vs 50 
picomoles) as is expected given previous results. And clearly less enzyme 
activity is seen in comparing between the 50 picomoles and that bound, though 





Construction of the functionalized uni-lamellar capsules is based on the charged 
polymers chitosan and alginate for self-assembly as has been used in previous 
works10,205 and has been referred to as a one-stage procedure206. ATP (10mM) 
was mixed with alginate (2.5%) for final concentration of 222µM ATP, vortexed, 
and added drop-wise by syringe needle (27G) to a magnetically-stirring solution 
of 1.1% (w/v) chitosan and 0.27% (w/v) CaCl2. The alginate-chitosan capsules 
were left in the solution for 10 minutes before being removed and rinsed in 0.02% 
(w/v) CaCl2. These capsules were then transferred for individual attachment of 
the enzyme the outer diameter (1.375 mm) and shell thickness of capsules (0.2 
mm) were measured immediately after rinsing using an MVX10 MacroView 
fluorescence stereomicroscope. Figure 31 illustrates the construction and shows 
stereomicroscope images of green-labeled SsoPox-Gln bound to the outside of 
Figure 29: Activity of bound SsoPox-X.  
The above demonstrates the activity of bound and unbound SsoPox at two different AI-1 
concentrations. In chart A, 200 picomoles of unbound SsoPox were used and samples were 
incubated for 2 hours at 37 °C. In chart B, only SsoPox-Gln was tested and samples were 
incubated 1 hour, again at 37 °C. In both charts the bars are the average of three samples with 
standard deviations provided. P-values are calculated by Student’s T-Test, two tails, type 2; ** < 
0.008, *** < 0.0008. 
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the capsule. Note that here SsoPox-Gln is being non-specifically/non-covalently 
bound as the incubation with microbial transglutaminase broke down the capsule 
in the second step of the two-step attachment process. To bind the SsoPox-Gln 
non-specifically the capsules were incubated with the enzyme for 1 hour at 37 °C 
with shaking just as would be done for covalent binding. After incubation the 
capsules were rinsed three times with HEPES pH 7.0, again, just as is done after 
covalent binding. Fluorescence measurements of capsules in the plate reader 
revealed that capsule fluorescence was not statistically different than the well, as 
seen in Figure 30. This was anticipated, as efforts were made to employ similar 
amounts of protein in the wells as in the capsules, based on similar surface 
areas. This may indicate higher amount of SsoPox-Gln binds per surface area of 
the capsule (146 picomoles/cm2) vs the well (109 picomoles/cm2) based on the 
slightly smaller average surface area of the capsules. Again even with this higher 
degree of binding per surface area, and likely due to binding within the matrix, 
the enzyme layer (4.5 x10-7 cm) is still less than 0.1% of the chitosan layer of the 
capsule (0.2mm).  
Figure 30: SsoPox-Gln binding: Well vs Capsule.  
Here the raw fluorescence as produced by SsoPox-Gln 
bound to the bottom of the well of a 96-well plate and 
to a capsule after washing is shown. The bars are 
representative of the average of three samples with the 
error bars representing the standard deviation. Here it 
is clear that while there does appear more binds to a 




Using this non-specific binding technique, where, in neutral pH the negatively 
charged SsoPox-Gln, pI 6.28, is bound to the outside of a likely positively 
charged chitosan, the capsule was tested for its ability to quench the AI-1 
communication signal. As shown in Figure 32, capsules were incubated in two 
different concentrations of AI-1 and aliquots of the solution were taken two hours 
after 2-hour incubation at 37 °C. These same aliquots were measured with both 
the luminescent and the Red-Green fluorescent reporter. Here the non-
specifically bound SsoPox-Gln is shown to reduce AI-1 activity at both 
concentrations. In addition this data demonstrates that the two reporters produce 
comparable results. In Figure 32A a reduction of AI-1 activity by 44% in the case 
Figure 31: Capsule construction for AI-1 lactonase quenching.  
As illustrated in Figure A, capsules were constructed by dropping either 2.5% w/v filtered alginate 
or a mixture of 2.5% w/v filtered alginate and 222µM ATP via 27G needle into stirring Chitosan-
CaCl2 to form capsules (A1) which were then incubated 10 min (A2). The capsules were removed 
from the incubation media and rinsed in 0.02% w/v CaCl2 (A3) before binding (A4) and 
subsequent quenching. Images of the capsules as taken by a stereo-microscope (B1, B2) are 
shown in Figure B. Here green fluorescently-labeled SsoPox-Gln is bound to a capsule. 
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of starting with 20 µM as indicated by the luminescent reporter, which could 
indicate a final concentration of approximately 11 µM AI-1. While relevant 
concentrations for P. aeruginosa are in the nanomolar range, reducing OdDHL 
(AI-1) concentration below 70 uM has been shown eliminate the antibody 
inhibition caused by higher concentrations of the molecule237.  
 
4.4 Discussion and Conclusions 
The addition of tags to the N- and C-termini has provided new opportunities for 
purification and function/delivery of SsoPox. Simpler purification could provide 
opportunities for yield improvement and attachment to surfaces means that this 
Figure 32: SsoPox-Gln capsules for AI-1 quenching.  
The above demonstrates the activity of SsoPox-Gln bound to the outside of capsules using two 
different AI-1 reporters, and illustrates the reaction in A. In B the luminescent reporter is used to 
measure remaining AI-1 activity after samples were incubated for 2 hours at 37 °C. In C, the 
same samples were measured with the red-green fluorescent reporter and the chart reflects the 
percent of cells fluorescing as counted from a total of 50,000 using flow-cytometry. In both charts 
the bars are the average of three samples with standard deviations provided. P-values are 
calculated by Student’s T-Test, two tails, type 2; * < 0.03, ** < 0.008. 
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powerful enzyme can be immobilized and delivered to specific areas for 
treatment.  
Both modified SsoPox enzymes proved to maintain lactonase activity in solution. 
In addition, SsoPox-Gln demonstrated a statistically significant reduction of AI-1 
activity and therefore lactonase activity when bound both covalently and non-
covalently. Given previous success in quenching a wide variety of AHLs/AI-1 
molecules, it would be prudent to verify that the promiscuous lactonase activity of 
SsoPox63 was also maintained after modification. In addition, activity in the 
nanomolar range should also be verified as it is within this range, specifically 
between 5 and 20 nM, that Pseudomonas aeruginosa demonstrates 
transcriptional activation due to the OdDHL-LasR complex binding to the DNA 
binding site238,239. 
With the knowledge that these modifications for attachment and purification 
yielded viable enzymes improvements could be made. It would be possible to 
perform site-directed mutagenesis, as has been done previously, to improve the 
activity of the enzyme and stability in environments lacking cobalt63,240. Mutation 
for improved lactonase activity in the SsoPox-Tyr variant would be particularly 
useful, as there was significant yield improvement and a simpler covalent binding 
mechanism.  
Adding the hexa-histidine tag made SsoPox purification by metal-affinity columns 
possible. In addition, this modification to the N-terminus may positively affect the 
activity of the modified SsoPox. Previously, it was shown that adding a hexa-
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histidine tag on the N-terminus of lactonases/PTEs, or organophosphotases 
(OPHs), increased OPH catalytic activity241. As organophosphate hydrolysis 
activity was not tested on the modified enzymes this would a logical next step in 
evaluating these new variants of SsoPox. Should activity be maintained, or even 
improved, these new enzymes would have much broader applications beyond 
biofilm prevention. Organophosphates, while not as commonly used in fertilizers 
are increasing being used as fire-retardants242,243. 
Providing the capability to covalently bind a powerful lactonase/organophosphate 
hyrdolaze to surfaces using amine groups provides a new tool for functionalizing 
surfaces. Activated amine groups are commonly used to bind enzymes for 
surface functionalization and increasingly used for carbon-capture212. Using this 
readily available binding technique means that the enzymes modified here could 
be attached to a wide variety of surfaces from graphene to activated fabrics244.
89 
 
5 CHAPTER 5: TAKING A MULTIFACETED APPROACH 
TOWARD QUORUM QUENCHING 
5.1 Introduction 
A system capable of quenching both autoinducer-1 (AI-1/AHL) and autoinducer-2 
(AI-2) bacterial communication molecules has been constructed. Enzymatic dual-
quenching provides the capability to effect phenotypes of multiple types of 
bacteria. In addition, it could mitigate adverse effects of only quenching a single 
bacterial communication pathway. For example, OdDHL and P. aeruginosa’s 
production of pyocyanin has been shown to have antibiotic activities96, however if 
pyocyanin production is reduced due to elimination of OdDHL, it would be 
advantageous to have another quenching capability to combat remaining 
bacteria. Additionally, the use of SsoPox, a promiscuous lactonase63, could 
provide quenching of other mid- to long-chain AI-1 molecules in addition to 
OdDHL affecting a broader range of bacteria. An illustration of this system is 
found in Figure 33, where two enzymes are bound to the outside of a biopolymer 
capsule containing ATP. 
 
Figure 33: Dual quenching capsule.  
The multifunctional quorum quenching capsule developed is the first to modulate two classes of 
bacterial communication molecules, autoinducer-2 (AI-2) and autoinducer-1 (AI-1) simultaneously 
using two different naturally produced enzymes. 
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5.2 Materials and Methods 
 
The plasmid pETLsrK-Tyr was used to express the AI-2 kinase, LsrK, fused with 
a spacer and tyrosine tag, herein referred to as LsrK-Tyr. To construct the 
plasmid, E. coli lsrK (ydeV) was amplified with primers as indicated in Table 1 
from E. coli W3110 genomic DNA using Vent DNA polymerase (New England 
Biolabs; NEB). After purifying the PCR product via the QIAquick gel extraction kit 
(Qiagen), the blunt-ended fragment was inserted into pET200/D-TOPO 
(Invitrogen), which has a hexa-histidine tag at the N-terminus for purification after 
the protein expression. The sequence of pETLsrK-Tyr was confirmed by 
sequencing facility (DNA Core Facility of the Institute for Bioscience and 
Biotechnology Research, University of Maryland). After transforming the plasmid 
into the BL21 (DE3) host strain, the LsrK-Tyr enzyme (MW: 62.9 kDa) was 
expressed and purified. 
 
The SsoPox genetic sequence was optimized for E. coli using the IDT codon 
optimization tool and the gBlock and primers for insertion into pET200 plasmid 
were ordered from IDT (Coralville, IA, USA). The SsoPox gene was amplified 
with Q5 (NEB, Ipswich, MA) and ordered primers for insertion into the pET200 
plasmid and addition of the glutamine tag. The sequence of the resultant plasmid 
(pSsoPoxG) was verified by Genewiz (Frederick, MD). After transformation into 
E. coli BL21(DE3) pLysS cells the enzyme SsoPox-Gln (MW:38.719 kDa) was 




Construction of the functionalized uni-lamellar capsules is based on the charged 
polymers chitosan and alginate for self-assembly as has been used in previous 
works10,205 and has been referred to as a one-stage procedure206. ATP (10mM) 
was mixed with alginate (2.5%) for final concentration of 222 µM ATP, vortexed, 
and added drop-wise by syringe needle (27G) to a magnetically-stirring solution 
of 1.1% (w/v) chitosan and 0.27% (w/v) CaCl2. The alginate-chitosan capsules 
were left in the solution for 10 minutes before being removed and rinsed in 0.02% 
(w/v) CaCl2. These capsules were then transferred for individual attachment of 
the enzyme. Figure 34 illustrates the construction of the capsule. 
 
5.3 Results 
The first step, as had been done previously with each enzyme individually, was 
to test activity of the two enzymes in solution. Each of LsrK-Tyr, 200 picomoles, 
Figure 34: Capsule Construction.  
The multifunctional quorum quenching 
capsule developed is the first to 
modulate two classes of bacterial 
communication molecules, 
autoinducer-2 (AI-2) and autoinducer-1 
(AI-1) simultaneously using two 
different naturally produced enzymes. 
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kinase activity SsoPox-Gln lactonase activity was tested in AI-1 (OdDHL, 225 
µM), AI-2 (15 µM, with 30 µM ATP) and a solution of both quorum sensing 
molecules (225 µM OdDHL, 15 µM AI-2 and 30 µM ATP) in a total volume of 100 
µL, using HEPES pH 7 to complete the volume. In addition, LsrK-Tyr and 
SsoPox-Gln were combined and tested under the same conditions as previously 
listed and corresponding kinase and lactonase activity was tested. In samples 
where LsrK-Tyr or SsoPox-Gln were not present an equivalent volume of the 
appropriate enzyme storage buffer was added. Each condition was completed in 
triplicate and incubated in the same 96-well plate for 2 hours at 37 °C with 
shaking. The full volume of the samples were stored at -20 °C overnight. The 
next day these samples were thawed on ice and vortexed to ensure uniformity. 
From these, AI-2 samples were taken directly for the BB170 assay and an aliquot 
was diluted for detection with the AI-1 luminescent reporter. The results of these 
assays is found in Figure 35 
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In Figure 35A the AI-1 activity is measured across all samples containing AI-1. In 
the third and fourth column it is shown that there is a statistically significant 
decrease in AI-1 activity in the presence of SsoPox-Gln, both with and without AI-
2. In addition, in the seventh and eighth columns it is shown that there is a 
statistically significant decrease in AI-1 activity in the presence of both and LsrK-
Tyr and SsoPox-Gln, It is also interesting to note here that the presence of LsrK-
Tyr did reduce AI-1 activity both with and without the presence of AI-2 and ATP. 
It is possible, though not verified, that LsrK-Tyr in the presence of ATP is acting 
as a homoserine kinase, which have been shown to phosphorylate L-
homoserines245. While ATP concentration was not measured to confirm this, it is 
noted that ATP binds to LsrK first in the phosphorylation of AI-2 as shown by Zhu 
Figure 35: Enzyme activity in mixed environment.  
A and B above have been generated from the average of three samples. When both AI-1 and AI-
2 were present aliquots from the same samples were measured by both means. The samples 
were incubated in a 96-well plate for 2 hours at 37 °C, and aliquots were taken for measurement 
of AI-1 and AI-2 concentration. Figure A shows the luminescent measurement of AI-1 activity 
using the cells from Lindsay et al. Figure B shows the relative luminescence of the BB170 assay. 
It is noted that the BB170 assay does not indicate AI-2 activity in the presence of the 225µM 
concentration of AI-1. However, AI-2 is detected when there is less AI-1 as in the fourth bar, 
where the SsoPox reduces the concentration of AI-1. P-values are calculated using a Student’s 
T-Test, two-tailed, type 2; * < 0.03, *** < 0.0008. 
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et al. 65, and therefore would provide LsrK with the capability to phosphorylate 
another molecule.  
In Figure 35B the AI-2 activity is measured across all samples containing AI-2. In 
columns five and seven it can be seen that LsrK-Tyr reduces AI-2 activity in the 
presence of SsoPox-Gln. It is noted that there is a reduction in AI-2 activity in 
column eight, where both LsrK-Tyr and SsoPox-Gln are present when compared 
to column four where SsoPox-Gln is present, though this is not a statistically 
significant decrease. It is clear from the second column, the positive control 
containing both AI-1 and AI-2 that 225 µM of AI-1 results in an inability for the AI-
2 assay to measure AI-2. However, given the increase in AI-2 activity in the 
fourth column, where AI-1 activity is reduced, there is indication that a lower AI-1 
concentration may provide the capability to measure both AI-2 activity in the 
presence of AI-2.  
With this information, it was determined prudent to move forward with testing 
simultaneous activity of immobilized enzymes on the outside of a capsule as 
illustrated in Figure 33. First, it needed to be determined if both enzymes could 
be non-specifically bound to the outside of a single capsule. Using the same 
DyLightTM Sulfhydryl-Reactive Dye as used previously, with SsoPox labeled in 
green and LsrK labeled red, both labeled enzymes (100 picomoles of each) were 
incubated with a capsule for 1 hour at 37 °C with shaking. Upon completion of 
incubation the capsule was rinsed three times in HEPES pH 7.0. Several 
capsules were labeled in this manner. In addition, capsules were incubated 
without the enzymes and rinsed before being imaged with a stereo microscope 
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for Figure 36. Both enzymes were bound non-specifically as evidenced by the 
presence of both red (LsrK) and green (SsoPox) fluorescence on the same 
capsule in Figure 36 (A2/A3 and B2/B3). That is, in neutral pH the enzymes are 
negatively charged SsoPox (pI 6.28) and LsrK (pI 5.45) and bound to the outside 
of a positively charged chitosan layer on the outside of the capsule. During 
capsule formation the chitosan is never neutralized and while the capsule is 
placed in HEPES pH 7.0 allowing it to maintain some positive charge.  
 
Figure 36 demonstrates that both enzymes can be bound to the outside of the 
capsule as was done previously. Using ImageJ the intensity of the fluorescence 
was measured for the fluorescing capsules, the results of this analysis are found 
in the upper right corner of Figure 36A2 and A3. Here it is clear that there is 
uniformity of fluorescence across the capsule, indicating uniform binding of both 
enzymes on the capsule.  
Figure 36: Combined capsules  
In figure A, two capsules, one with labeled enzymes, the other without enzymes are shown as 
imaged on a stereomicroscope in bright-field (A1, B1), red fluorescently labeled LsrK-Tyr (A2, 
B2), and green fluorescently labeled SsoPox-Gln (A3, B3). Figure B shows the same capsule cut 
to show the shell to which the enzymes are bound, again with half an unlabeled capsule.  
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Having demonstrated dual binding the next step was to verify LsrK kinase and 
SsoPox lactonase activity while both are bound to the same capsule. Capsules 
containing ATP were prepared with both enzymes as illustrated in Figure 34, 
rinsed and exposed to a solution of 20 µM AI-1 and 40 µM AI-2. This lower 
concentration of 20 µM AI-1 was used to avoid the issue seen earlier where 225 
µM AI-1 interfered with the BB170 Assay. Capsules were incubated in these 
solutions for 2 hours at 37 °C with shaking. At the completion of incubation the 
entirety of the solution was removed and stored at -20 °C overnight. Again, 
aliquots from these samples were used directly for BB170 Assay, and diluted for 
AI-1 concentration testing. The results of these assays can be found in Figure 37. 
In Figure 37A the AI-1 activity is measured after incubation, and it is clear that in 
the presence of SsoPox the AI-1 activity is reduced by a statistically significant 
amount as seen in columns two and four. In Figure 37B the AI-2 activity is 
measured, here it is clear in columns three and four that the presence of LsrK 
reduces the AI-2 activity. It is also noted that the reduced initial concentration of 
AI-1 provided the capability for the BB170, AI-2 activity, assay to provide a 
reading of AI-2 activity in the presence of 20 µM AI-1. It is noted, however, that 
the addition of the SsoPox capsule in column 2 did seem to increase overall 
luminescence in the BB170 Assay, though not in a statistically significant fashion, 
indicating there could still an adverse effect due to AI-1. Ultimately, there is 
statistically significant decreases in both quorum sensing molecules when both 
enzymes are present on the same capsule as seen in column four of both Figure 




It had been noted previously that ATP is a limiting factor in LsrK-Tyr kinase 
activity in quenching AI-2. As a result, a second set of capsules were exposed to 
solutions containing the same concentration of AI-1 (20 µM) and AI-2 (40 µM), 
however, 60 µM ATP was added to the solution. It is evident in Figure 38 that the 
addition of ATP (6 nanomoles, final concentration 60 µM) does improve the 
overall performance of the system, providing more statistically significant 
decreases in both AI-1 and AI-2 concentrations. The added ATP, which is six 
times that found in a single capsule (see Appendix A), is one and one half times 
the amount of AI-2 present in solution. This additional ATP is also readily 
available for binding to LsrK and subsequent phosphorylation of AI-2, while that 
contained within the capsule is not only insufficient for one-to-one 
phosphorylation, but could be contributing to crosslinking of chitosan as was 
Figure 37: Dual-quenching delivered in a single functionalized capsule.  
A and B above have been generated from the average of three samples. Aliquots from the same 
samples were measured by both means. Three samples of each condition were incubated in a 
96-well plate for 2 hours at 37 °C, and aliquots were taken for measurement of AI-1 and AI-2 
concentration. Figure A shows the luminescent measurement of AI-1 activity using the cells from 
Lindsay et al. Figure B shows the relative luminescence of the BB170 assay indicating AI-2 
Activity. P-values are calculated using a Student’s T-Test, two-tailed, type 2; * < 0.03, ** < 0.008. 
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seen previously213. Again a decrease in AI-1 concentration was noted in the 
presence of LsrK and ATP, but the result was not statistically significant. 
 
 
Figure 38: Adding ATP improves performance of dual-quenching capsules.  
As in Figure 36, A and B above have been generated from the average of three samples.. Here 
ATP was added to the samples during incubation in a 96-well plate for 2 hours at 37 °C, and 
aliquots were taken for measurement of AI-1 and AI-2 activity. A shows the luminescent 
measurement of AI-1 activity using the cells from Lindsay et al. B shows the relative 
luminescence of the BB170 assay indicating AI-2 Activity. P-values are calculated using a 
Student’s T-Test, two-tailed, type 2; * < 0.03, ** < 0.008. 
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6 CHAPTER 5: CONCLUSIONS 
6.1 Results Summary 
In this work, for the first time, a functionalized capsule of modified quorum 
quenching enzymes and biocompatible polymers has been constructed and 
demonstrated to have dual quenching capability. 
In chapter 2, an AI-2 quenching capsule was developed using biopolymers and a 
modified form of the natural kinase, LsrK, with its primary substrate, ATP. Two 
modified forms of LsrK were engineered with tags for immobilization, produced, 
purified and verified for activity both in solution and when bound. Both 
modifications of the kinase were successful in phosphorylating AI-2 in vitro and 
rendering the signal unrecognizable to V. harveyi reporter cells. With significantly 
more activity, the tyrosine-tagged LsrK-Tyr was used to demonstrate activity 
when covalently bound to both a chitosan film and the outer layer of a chitosan-
alginate capsule. Furthermore a functionalized capsule composed of 
biocompatible biopolymers that delivers the modified LsrK with its primary 
substrate, ATP, was developed and demonstrated robustness in mixed culture 
environment. 
In chapter 3, an AI-1 quenching capsule was developed using the same 
construction as in chapter 2, replacing the kinase with the promiscuous 
lactonase, SsoPox. Here, SsoPox was, for the first time, modified with tags at the 
N- and C-terminus, produced, purified and verified as active. A hexa-histidine-tag 
was added at the N-terminus for ease of purification, and two different tags were 
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added to the C-terminus for covalent binding to chitosan. Both forms of SsoPox 
proved active in solution, that is, rendering the AI-1, OdDHL, unrecognizable. 
However, SsoPox-Gln, performed better when covalently bound to a chitosan 
film. A new fluorescent cell reporter was also constructed in this work that 
provided a means of indicating AI-1 presence without affecting the amount of AI-
2 in the environment. Using LasR and the DNA binding site from P. aeruginosa, 
these reporter cells produce green fluorescence in the presence of OdDHL. 
Ultimately a capsule with bound SsoPox-Gln was produced that proved to 
quench the AI-1, OdDHL. 
In chapter 4, the modified enzymes, LsrK-Tyr and SsoPox-Gln, were first 
demonstrated to be simultaneously active in solution, quenching two different 
quorum sensing signals. This was the first time both AI-2 and AI-1 have been 
enzymatically quenched in the same in vitro environment. Finally, these two 
enzymes were bound to the developed capsule to provide a functionalized dual-
quenching device.  
6.2 Broader Impact  
Bacteria rarely, if ever, exist in a single-species environment outside of the lab. 
Bacteria on the skin, in the gut, in the mouth, in the soil and associated with most 
infections are comprised of several species of bacteria. And, as has been 
mentioned, many of these bacteria have multifaceted means of biofilm formation 
and toxicity; so multiple signals need to be quenched to adequately prevent 
biofilm formation. This research demonstrates two powerful quorum quenching 
enzymes are active simultaneously to provide a multifaceted approach in 
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preventing biofilm formation, which is an important step in using quorum 
quenching as a substitute for antibiotics. 
By combining two quenching enzymes this could provide greater insight into 
biofilm formation by modifying the bacteria environment rather than modifying 
bacteria directly. Often, in research settings, bacteria are modified to understand 
how the quorum sensing enzymes (or absence thereof) effects phenotype 
including biofilm formation. This capability to modify the bacteria culture 
environment may aid in academic research to better understand the dynamic 
environment of single, or even multi-species cultures. In addition to academic 
applications this dual approach provides a more powerful way to effect changes 
to the multi-species environments that often compose infections. As a result this 
multi-faceted approach has the potential to prove a more powerful 
implementation of quorum quenching in preventing virulence.  
Each of these quenching enzymes has been engineered for covalent binding to a 
biopolymer surface. This covalent binding provides the capability to not only 
deliver the quorum quenching enzymes to a specific location/environment, but 
coat surfaces with active enzymes to prevent biofilm build-up. The nature of the 
binding reaction makes it is possible to bind the enzymes in tubes and small 
spaces and rinse away the binding agent, leaving only the enzyme. By providing 
a means of functionalizing surfaces with enzymes it provides a new way of 
preventing biofilm formation without affecting the broader environment.  
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Additionally, there is the potential for the capsule, or a modified form, to be used 
as part of treatment of intestinal ailments. This capsule, in contrast to cell-based 
solutions, could provide a time-limited AI-2 and AI-1 depletion. This approach 
could reduce impacts of harmful pathogens and allow the resurgence of normal 
gut biome, which has been shown to require AI-2246. 
6.3 Challenges  
While the amount of each enzyme bound to the surface area of the film and 
capsule has been calculated, determining the amount of each enzyme in a 
combined environment is a larger challenge for the current system. The manner 
by which the current films and capsules are constructed precludes a specific way 
to differentiate proportions of each enzyme bound. In addition, because SsoPox 
is approximately half the size of LsrK it is possible that twice as much will bind 
based on size alone. However, because the two enzymes have different binding 
modalities, it should be possible to specify the amount of each in other systems, 
where surface properties can be manipulated at the molecular level. 
While there is a reduction in both quorum sensing signals, neither has been 
demonstrated to be completely eliminated from the environment in this work. 
Reducing AI-2 concentration to below 5 µM was demonstrated to have lead to 
less biofilm formation than higher concentrations (11 µM) and therefore reducing 
to these low levels may be sufficient to reduce virulence caused by biofilms32. As 
mentioned previously, a minimum level of AI-2 may aid ensuring the natural 
biome is maintained, though additional work would need to be conducted to 
determine preferable levels of AI-2 in the health gut biome. 
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In addition low levels of AI-1 seem not to be detrimental to mammalian cells237, 
however because the molecule can have antibiotic properties and is an 
autoinducer it would be preferable to more completely eliminate this molecule to 
a nanomolar level239. Additional reduction could be achieved with the use of 
additional enzymes, perhaps through delivery with smaller particles. In the case 
of AI-1 elimination this would particularly advantageous as the SsoPox hydrolysis 
is significantly slower than the phosphorylation as completed by the LsrK kinase.  
Although the capsules constructed here provide a degree of quenching of the 
‘universal’ quorum-sensing signal, AI-2 and a widely recognized AI-1, with 
potential for quenching other AHLs based on the enzyme’s previous 
performance, this is only a start. Bacterial infections are often a multi-faceted 
environment. As a result, while quenching two common quorum sensing 
molecules will aid in reducing biofilm formation and pathogenicity of some 
bacteria, other molecules need to be quenched to further reduce the toxic effects 
of bacteria.  
Specifically, a third class of quorum sensing molecules, autoinducing peptides 
(AIPs), are not addressed. AIPs that bind to transmembrane receptors are used 
by Gram-positive bacteria 27,100,101 including C. difficile91. This addition would also 
be particularly valuable in addressing S. aureus and S. epidermis infections. It 
has been shown that genes coding for virulence, including apoptosis proteins 
and inflammatory peptides, are under the control AI-2 system as well as the agr 
system which recognizes AIPs in S. aureus and S. epidermis 247,248. Of particular 
note in making this addition is that a lack of AI-2 has been attributed to increased 
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biofilm formation249 and resistance to phagocytes by S. aureus85. As a result, 
providing a system that not only quenches AI-2, limiting biofilm formation and 
virulence of several species of bacteria, but also quenches the AIPs that cause 
toxicity in S. aureus would be highly advantageous.  
6.4 Future Directions  
First, it would be beneficial to understand the full capabilities of the lactonase-
activated capsule. Additional testing of the modified SsoPox enzyme, both bound 
and unbound would be required. Particularly of interest would be determining if 
the enzyme maintains the promiscuous lactonase and organophosphate 
hydrolysis activity of the original enzyme63,229,240. Should this be the case, there 
would be far broader implications of the capsules. Specifically they would have 
the capability to quench many more AHL molecules, such as those use by Y. 
pestis250. However, perhaps more profoundly, the capsules would have the 
capability of immobilizing an enzyme capable of neutralizing the harmful 
neurological effects of organophosphates222.  
Given that these capsules have the capability to impact many of the most 
prevalent antibacterial resistant strains, it would also be recommended to test the 
impact on C. difficile directly. This harmful bacterium flourishes in the gut when 
the natural biome is degraded by administered antibiotics, leading to further gut-
biome degradation as C. difficile itself produces toxin which targets other 
bacteria91. Research suggests that C. difficile has a LuxS-like enzyme3, that 
                                            
3 LuxS produces AI-2 in other bacteria 
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when absent, prevents the formation of biofilms33. While other sensing molecules 
have been directly related to toxin production91, the capsules in present form may 
have an impact on C. difficile by reducing the amount of AI-2 in the environment, 
and may also provide greater insight into C. difficile biofilm formation and toxicity.  
Finally, the AI-1 reporter could be modified for AI-1 quenching by inserting the 
SsoPox gene where the sfGFP is currently. By quenching the AI-1, OdDHL, this 
new cell could allow additional growth of beneficial Gram-negative bacteria and 
reduce the impact to mammalian cells88.
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7 APPENDIX A: MODELING ATP DIFFUSION OUT OF 
CAPSULE 
7.1 Introduction 
Using data collected in capsule development and verification of quorum 
quenching a mathematical model can be constructed for use in future work. 
Modeling the quorum quenching systems designed herein requires consideration 
for mass transfer and reaction kinetics. For the first quenching capsule, loading 
of ATP in the capsule, ATP release or diffusion from the capsule should be 
considered. For both capsules the reaction kinetics will be considered; the 
phosphorylation of AI-2 by LsrK-Tyr for the first capsule and hydrolysis of 
OdDHL. The capsules are assumed to be a uniform spherical core with a uniform 
spherical shell so that diffusion is symmetrical.  
Preliminary modeling was done in Matlab R2012b (Mathworks, Natick, MA). 
7.2 Modeling AI-2 Quenching  
Mathematical modeling of solute diffusion in a hollow capsule has been proposed 
by Yao et al251, and supported experimentally by Zhang et al 252. However Yao 
and Zhang’s model measures the diffusion of the solute from a bulk solution into 
a capsule as has been done in other characterizations of calcium-alginate beads 
253 and is explained by Truskey et al 254. In this study, and other bead and 
capsule characterizations, the concentration inside the bead or capsule is known 
and diffusion into solution is measured255,256. Tanaka et al 257 has provided an 
equation for the diffusion from spherical beads as was derived by Crank258, and, 
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as a result, creation of the model starts with the same mass balance equation as 
in Crank258.  
In preliminary tests it was noted that capsules swelled when removed from 
chitosan and placed in other solutions. This is assumed to be due to osmolarity 
differences between the capsule alginate core and the solution. Because swelling 
increases the radius this affects ATP diffusion and is considered in the model.  
The initial conditions are as follows where CA is the overall capsule 
concentration, CAi is the initial capsule concentration and Cb is the bulk solution 
concentration: 
, 0  				,				  	  			,							0   
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Where rS is the outer diameter of the 
capsule, rC is the outer diameter of the 
capsule core/inner diameter of the capsule 
shell, DS is the diffusion coefficient of the 
capsule shell, and DC is the diffusion 
coefficient of the capsule core, as illustrated 
in Figure 39A. 
Figure 39A: Illustration of capsule 
This illustration of the capsule with the 
boundary layer film illustrates the system 
being modeled by the preliminary model. 





For the AI-2 quenching system, ATP is delivered with LsrK5’-1 and diffuses out of 
the capsule to first bind to LsrK5’-1 and then phosphorylate AI-265. The 
encapsulation efficiency was calculated by the equation below. Where ATPA is 
the measured/actual loading and ATPT is the theoretical loading, 222µM.  
%     ∗ 100		 3 
Known concentrations of ATP in LB were plotted against their measured 
luminescence. The plot was compared to the manufacturer’s specification, and 
an exponential line of fit was determined with R2 value over 0.98 to determine 
concentration based on luminescence for LB as plotted in Figure 40. Using the 
steady-state bulk concentration of 2.1 µM of LB, as can be seen in Figure 40, the 
initial concentration per capsule can be calculated and was found to be 120 µM4, 
which is an encapsulation efficiency of 54%, similar to that found in other work213. 
The reasonably low encapsulation efficiency may be due in part to the low 
molecular weight of ATP, 507g/mol, as Tanaka et al showed L-trytophan, 204 
g/mol, diffused into Ca-alginate beads in less than 30 min and similar results for 
fast initial ATP release have been seen in other work213. Note that in this work 
capsules were not measured for ATP concentration until at least 10min after 
formation, due to rinsing and incubation in CaCl2 solution.  
                                            
4 =(0.0000021M* 0.005L)/8 capsules/10.9 µL per capsule 
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The characteristics of the ATP molecule is another factor that should be 
considered. In some studies sodium tripolyphosphate (Na-TPP) is used to 
crosslink chitosan membranes259, and ATP has a similar structure, size, and 
charge, and therefore may also be crosslinking chitosan. In addition, ATP has 
been shown to stabilize the structure of alginate calcium carbonate gels260. Qi et 
al found a decrease in the UV-vis absorption peak for ATP, 558 nm, after one 
minute of reacting with CaCl2, Na2CO3 and ATP, and there was a positive 
correlation between CaCO3 absorption and ATP concentration. As a result, it is 
possible that ATP is being crosslinked with alginate.  
 
The diffusion of ATP through the core and the shell of the capsule must be 
considered when determining the overall diffusion coefficient of ATP from the 
capsule. This includes both the binary diffusion coefficient of ATP in the viscous 
alginate core and the effective diffusion coefficient of ATP across the alginate-
chitosan cross-matrix shell of the capsule, both of which are assumed to maintain 
a spherical shape. In this preliminary model no partition coefficients are 
calculated or included. It is assumed that the initial ATP concentration, based on 
loading efficiency, is the same in both the core and the shell, CAi.  
Below is the equation for substrate concentration in the bulk solution as provided 
by Crank and Tanaka, where rS is the outer radius of the capsule, t is time and 
the liquid film or boundary layer is included in the model 257,258  











 <  =>?@A20@   5  
Where V is the volume in the bulk solution, 5ml, or 5000mm2 and N is the 
number of spheres, 8, 252. qn are non-zero positive roots of Equation 6, for this 
work the first ten roots will be used:  
tan E9 ! F+,F+,-  0  6 
Dall, can be defined in terms of DC, DS, rS, and rC when applying the same 
conditions as in Yao et al251. The diffusion coefficient in the core, DC, is assumed 
to be that of ATP in aqueous solution as has been found a reasonable 
assumption in previous work for diffusion of similarly sized and larger substances 
in and out of Ca-alginate and Ca-alginate-chitosan capsules252,257. As a result, 
the diffusion of ATP through the core, DC = DW = 3.5x10-6 cm2/sec 261, or 2.1x10-2 
mm/min. The shell diffusion coefficient, Ds, is assumed to be 10% that of ATP in 
aqueous solution as was found to be the diffusion coefficient for L-tryptophan, a 
similarly sized molecule passing through an alginate-crosslinked 
shell/membrane252.  
The initial capsule weight was determined by averaging the weight of nine rinsed 
and dried capsules and found to be 9.8mg. Because the initial total weight of 
ATP in the capsule at the start of formation is 1.12 µg5 or 0.03% of the average 
                                            
5 1.12µg=(0.000222 M*0.000010 L)*507.18g/mol 
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initial capsule weight the change in capsule weight due to ATP release is 
considered negligible.  
The capsule weight was used to calculated shell radius, rS. The weight increase 
is the result of osmosis into the capsule255,262. Because water has a known 
density of 1 g/mL or 1 µg/mm3 the shell radius at time, t, rSt, can be calculated by 
G  H FIA J	 + LG ! L	@  7 
Where Vi is the initial volume of the capsule as calculated from initial diameter, 
Wi is the initial weight in grams and Wt is the weight in grams at time t=t. Figure 
40 shows the average weight with standard deviation for three samples, which 
increased steadily over time. This average weight was used to calculate the outer 
capsule radius, which was also plotted vs time and a line of best fit was 
determined such that the R2 value greater than 0.95. This line of best fit was 
used to represent rs and as input for calculation of α. We assume that only the 
core is swelling due to osmosis. Shell thinning is assumed to be linear according 
to studies conducted previously on chitosan alginate films in mixed solutions of 
PBS263. The initial and final shell thicknesses were used to find a linear function 
of the value of shell thickness, st which was used for all solutions. Using the 
function of shell thickness combined with the calculated shell radius, core radius, 
rc can be determined using Equation 8. The initial and boundary conditions are 
as follows: 
G  G ! MG  8 
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MG:N  0.2mm, 0 ≤ S ≤ MG	, T ≤ 0	,   			MG:N  0.2UU			G:N  1.375mm	, G:N 
1.275	 9 
0 ≤ S  MG	, T ≥ 0	,   												S  MG	, T ≥ 0	,   				 10 
Capsules were measured and then sliced open to find initial diameter, radius and 
thickness of the chitosan-alginate shell was found. Given that the initial shell 
thickness is 0.2mm, a new equation for effective diffusion was calculated. The 
initial and final shell thicknesses are used to find a linear function of the value of 
shell thickness, st which will be used for all solutions. 
MG  Z.[\'Z.[]G\ t + MG:N  11 
And the overall diffusion coefficient is, where ^ is the width of the boundary layer, 
0.01mm, and DF=0.001*DW is the diffusion coefficient through this boundary 
layer. 
_`aa  b20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Plotting this concentration profile with an initial capsule ATP concentration of 
120µM yields a good representation of the initial ATP release as seen in Figure 
40A, which also shows the subsequent effect on reaction kinetics. While this 
model doesn’t reach the concentration measured in 120 minutes, it does appear 




As was demonstrated, the modified protein LsrK-Tyr is still active and capable of 
phosphorylating AI-2 when bound to chitosan. Based on DNA sequence analysis 
and verified enzyme activity, it is assumed that the enzyme active-site has not 
been altered in LsrK-Tyr and that reaction kinetics found in previously work still 
hold65, where, for the purposes of this study, DPD and AI-2 are equivalent.  
Zhu et al, using fitting and replot analysis against Michaelis-Menten, found that 
the reaction kinetics of LsrK were dependent on both ATP and DPD 
concentration, with ATP binding occurring first65. Using the data from Zhu et al 
the concentration profile can be used to show a reaction kinetics profile with 
varying concentrations of DPD.  
With a known concentration of either substrate Zhu et al through experimentation 
found values that could be used in the Michaelis-Menten equation. Here v is the 
reaction rate, [S] is the substrate concentration or ATP in bulk solution, Cb, Vmax 
is the maximum rate at which the reaction can take place, which will vary 
dependent on DPD concentration, and Km, the Michaelis constant is the 
concentration of ATP when the reaction rate is at half its max.   
d  =e)fghiegh 13 
The model uses the concentration determined by Equation 4 for the ATP 
concentration, [S], in the Michaelis-Menten equation. Because the initial 
concentration of ATP in the capsules, 222uM, is less than saturation65 the Vmax 
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and Km values will be estimated from Zhu et al, depending on the AI-2/DPD 
concentrations being plotted. 
d  =e)fgjkjh	liegjkjhl  14 
Preliminary model results in Figure 40A shown that reaction velocity mirrors the 
concentration profile, as was expected based on the work of Zhu et al. In 
addition, increased reaction velocities are correlated with increasing 
concentrations of DPD/AI-2, which are less than those seen in the work of Zhu et 
al, as the ATP concentration is only approximately 2µM compared with the 
500µM and both the ATP and AI-2 concentrations affect the overall reaction rate.  
Figure 40A: Preliminary AI-2 Quorum Quenching Model 
The Luminescence shown in the first graph is a plot of the measured luminescence normalized to 
luciferase vs known concentrations of ATP. The line of best fit on the graph is used for conversion of 
luminescence in measure of ATP concentration as the known values were in the sample set. The second 
graph are the measured weights of capsules over time. The third graph is the calculated radius as a 
result of the measured weight increase as a result of osmosis. The bottom two charts have been 
generated from the preliminary Matlab model. The first shows the measured ATP concentration as circles 
and the model as stars. The second shows the estimated reaction velocity at various concentrations of 
AI-2 based on the ATP release profile. 
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7.3 Modeling AHL Quenching Capsules 
Because lactonases require only water as a substrate for hydrolysis of AHLs, and 
it can reasonably be assumed that water will not be a limiting factor, the modeling 
of the AHL quenching capsule is primarily reliant on the enzyme kinetics of 
SsoPox-Gln, and the concentration of OdDHL.  
Hiblot et al, determined the reaction kinetics and constants of wild-type SsoPox 
with OdDHL, where kCAT is the number of substrate molecules turned to product 
per second by each enzyme, KM is the Michaelis-Menten constant, and kCAT/KM is 
the enzyme efficiency: 
kcat (1/s) = 1.01 ± 0.13 
KM (µM) = 456 ± 128 
kcat/KM (1/s*M) = 2.22(±0.68)x10363 
Using these values and a known initial concentration of the enzyme, SsoPox-Gln, 
[E]0, in the reaction the maximum velocity of the reaction, Vmax, can be calculated 
for input into the Michaelis-Menten equation to find the reaction velocity: 
Vmax = kcat*[E]0 15 
d  =e)fghiegh 13 
where [S] is the substrate concentration or OdDHL in bulk solution. 
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8 APPENDIX B: AI-1 REPORTER PLASMID DIAGRAMS 
 
Figure 41B. Red-Green Reporter plasmid map 
A map of the plasmid constructed for reporting on AI-1 concentration. The construct was placed 
into the p21A plasmid with ampicillin resistance. In addition the T7 promoter was removed and a 
T5 promoter added before the dsRed-Express2 gene. The bi-directional LasR-OdDHL binding 




Figure 42B. Green Reporter plasmid map 
A map of the plasmid constructed for reporting on AI-1 concentration with no working red gene. It 
is the same as the previous plasmid except that 200bps have been removed from 
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